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 Recent recognition of the pervasiveness of non-coding RNAs, in both 
prokaryotic and eukaryotic systems, has prompted metabolic engineers to reevaluate 
the role of RNAs in a traditionally protein dominated realm.  More specifically, 
bacterial trans-encoded sRNAs have been implicated in the regulation of genes in 
several critical pathways from quorum sensing to stress responses.  The task of 
responding to stressful conditions, as well as stationary phase, in a comprehensive 
manner falls to the Escherichia coli global stress regulator, RpoS.  Genes transcribed 
by RpoS are involved in motility, biofilm formation and nutrient limitations.  One of 
the challenges modulating RpoS control is its polymorphic nature.  We think this can 
be addressed using an inducible sRNA regulatory platform. 
 Recent studies have confirmed RpoS to be post-transcriptionally regulated by 
at least four sRNAs: three activators, DsrA, RprA and ArcZ, and one repressor OxyS.  
  
Each of these senses different stress conditions, allowing RpoS synthesis to increase 
or decrease in response to various stressors. This work investigates the potential of a 
genetically engineered interchangeable small RNA based gene regulation platform as 
a switch to affect the expression profiles and metabolic behavior of RpoS.  RprA and 
OxyS were put under the control of an arabinose inducible promoter to test the ability 
to increase/decrease RpoS protein levels and subsequent changes in RpoS-dependent 
genes. We then assessed gene expression and phenotypic changes using RT-PCR, 
Western blotting, microarray and motility and biofilm assays. Positive modulation of 
RpoS using the pRprA platform resulted in a 2 fold decrease in motility in Top10 
cells. This difference in motility improved biofilm formation levels up to 12 fold 
when compared to direct overexpression of RpoS protein. The positive effect of 
biofilm formation was further supported by the upregulation of other genes essential 
for biofilms.  Conversely, negative modulation of RpoS using the pOxyS platform 
resulted in an increase in the transcription of the motility gene, flhD.  Both systems 
were capable of positively and negatively regulating bacterial RpoS protective genes.  
The ability to deliberately and purposefully control RpoS protective genes, in 
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Bacteria are one of the more investigated and understood microorganisms in 
the scientific community due to its single-celled structure.  Consequently, the entir  
Escherichia coli (E. coli) genome was one of the first to be decoded and is readily 
accessible from a variety of sources.  However, this seemingly simple organism 
actually hosts over 4,000 genes that contribute to an intricate network of coordinated 
processes.  Even with all that has been elucidated about bacteria and E. coli in 
particular, in many aspects bacterial processes still remain somewhat nigmatic. 
Despite these challenges, researchers have successfully managed to make great 
strides not only in deciphering the nature of these vast networks but also employing 
them in a variety of technological advances, from industrial to medical.  
Concomitantly, we have also witnessed the emergence of new ways bacterial sp c es 
have learned to adapt and improve their survival techniques in response to some of 
these advances.   
This dilemma has probably received the most attention with regard to the 
medical community, as refractory microbes develop resistance to multi-spec rum 
antibiotics in the field of medicine.  The current state of antibiotic resistance exists 
due to a multitude of reasons including over-prescription by doctors and wide spread 
use in the food industry for disease control and as growth enhancers for animals.  
Exposure to antibiotics creates a natural environment for variants, bacteria wi h traits 




to an antibiotic can gain resistance by mutations or by acquiring DNA with res stance 
properties from other bacteria.  When these bacteria proliferate a new population of 
antimicrobial resistant bacteria emerges.  Additionally, bacteria often live in 
protective sessile communities, or biofilms.  The biofilm architecture is partially 
mediated by quorum sensing which allows bacteria to coordinate behaviors such as 
motility, virulence and stress responses, rendering bacteria increasingly resistant to 
antimicrobial agents. 
Bacteria used in biotechnology resist genetic modifications to increase protein 
yield.  Though the practice of overexpressing recombinant proteins in E. coli is 
widespread, the “metabolic burden” incurred by a host cell when producing a desired 
heterologous protein elicits a stress response that can result in reduced yields and 
degradation of the protein by cellular proteases.  The RpoS protein has been at least 
partially implicated in all of these scenarios.  RpoS leaves cells remarkably adaptive, 
yet resistant, to complete genetic manipulation. 
The task of responding to varied and potentially stressful circumstances in a 
comprehensive manner falls to the rpoS encoded sigma subunit of the RNA 
polymerase, σS (RpoS).   RpoS is responsible for protecting the cell against external 
stresses (e.g. nutrient limitations/starvation, temperature fluctuations, 
hyperosmolarity, heat, toxic chemical exposure, pH downshift, etc).  Essentially σS 
plays a role in E. coli flexibility, working in concert with other systems, helping the 
cell to protect vital processes and most importantly survive.  The ability to affect




strategy to affect metabolic pathways and approach the aforementioned problems 
from a more global perspective. 
The persistent challenge present with working with RpoS, is also its most 
remarkable feature, it mutability.  Studies have revealed numerous mutations in the 
rpoS gene resulting in different alleles not only among different strains but within the 
same strains, even strains that originated from the same parent.  This is attr buted to 
varying environmental conditions and the cell’s constant trade-off between self-
preservation and nutritional competence, or the SPANC balance, to maintain accurate 
levels of adaptation.  RpoS polymorphism makes it an even more difficult target for 
genetic engineering.  Any approach to modify RpoS behavior must take this factor 
into account. 
Bacteria maintain an elaborate, but flexible, signaling network and adjust 
cellular physiology accordingly.  Small noncoding RNAs are included in this 
complex regulatory circuitry.  While initially many small RNAs (sRNAs) were 
discovered fortuitously, the last several years have revealed their pervasivenes  in 
bacterial cellular regulation.  Due to the nature of their mode of action many sRNAs 
fall into the category of riboregulators.  Riboregulators provide a swift, adaptive 
response to diverse signals and modulate gene expression to accommodate versatil  
conditions.  In this way, sRNAs may provide a simple way to impose global 
regulation of a group of genes. 
The hallmark of sRNA riboregulation is rapid response to environmental cues 
and post-transcriptional regulation of mRNA and protein synthesis and/or stability, 




These small RNAs essentially function as sensors responding to outside stressor  and 
triggering a response, usually in the translation (repression or activation) of a  mRNA 
target(s), though a few protein targets exist.  In tra s-encoded sRNAs particularly, the 
success of this regulation has a smaller dependence on base pairing, requiring 
generally ~10-25 nucleotide base pairing interactions.  RpoS has been confirmed to 
be post-transcriptionally regulated by at least four small RNAs. The work here 
supports the use of small RNAs as a potential solution to genetically modulate RpoS 
metabolic gene expression profiles for directed downstream applications.  
 
Literature Review 
E. coli and sigma factor competition 
As an enteric bacterium, E. coli experiences diverse conditions ranging from 
the mammalian gut to soil, from anaerobic to aerobic.  The exposure to these ever 
changing surroundings requires bacterial populations to constantly switch between 
growth, survival, and death.  To assist in the vacillation between these various states 
E. coli is equipped with a host of pleiotropic regulators of gene expression.  The 
expression of these genes is dependent on the presence of seven sigma (σ) factors 
each selecting for the transcription of distinct promoters in the genome.  
Transcription is the initial step in gene expression and is prompted by E. coli 
RNA polymerase core enzyme (denoted RNAP or E) binding a DNA promoter site, 
transferring genetic information into RNA and typically protein.  The coreRNA 
polymerase complex consists of five subunits (α2ββ’ω) [1].  The α subunit, encoded 
by RNA polymerase A or poA, is necessary for RNA polymerase core complex 




encoded by rpoB, is involved in recruiting the sigma factors for RNAP holoenzyme 
assembly [3].  The β’ subunit, encoded by rpoC, participates in promoter melting, 
plus stabilizes the open promoter complex [4].  The ω subunit, encoded by rpoZ, aids 
in β’ folding, by preventing aggregation, and its subsequent assembly with rest of the  
catalytic core [5].  This subunit is key in the last stages of core enzyme assembly and 
has also been found to be necessary to restore denatured RNAP in vitro [6].  Only 
upon binding a sigma factor, the fifth subunit, is a complete holoenzyme formed 
which exhibits target promoter specificity (Figure 1) [7, 8].  A list of these seven 
sigma factors and their respective transcriptional functions is given in Table 1.   
There are two primary sigma factors, the rpoD encoded σ70, which is the main 
vegetative factor utilized for transcription during logarithmic or exponential phase 
[8], and σS (RpoS or σ38)   which is the prevalent factor during the transition from the 
exponential throughout the stationary phase, encoded by rpoS (also known as katF) 
[9, 10].   σS is also the master regulator of the general stress response [7].  The other 
five factors are usually only triggered by a particular stress signal(s) and hence are 
considered alternative, or minor, sigma factors.  The alternative factors include the 
rpoN encoded σ54 (or σN), which is activated by nitrogen deficiency [11], the rpoH 
encoded σ38 (or σH), which is activated by heat shock [12, 13], the fliA encoded σ28 
(or σF), which is involved in the synthesis of flagellar and chemotaxis genes [14, 15], 
the rpoE encoded σ24 (or σE), involved in the assembly, maintenance and repair of the 
cell envelope [16, 17] and fecI encoded σ19 (or σFecI), which regulates the ferric citrate 
transport system when iron is limiting [18].  The numbers denote the molecular mass 




seven sigma factors can be divided into two groups, the σ70 family, which consists of 
all the known sigma factors [19, 20] except σ54, which constitutes the second family.  
σ
54   has no homology to the other sigma factors and recognizes completely different 
promoter sequences [21]. 
 
Table 1 – E. coli sigma factors and their corresponding functions 
 
 
Calculations of core enzyme amounts suggest a limited amount of RNAP in 
the cell is actually available for transcription in vivo [22].  As a result, each of the 
seven sigma factors competes for affinity to the same amount of RNA polymerase 
[23, 24].  For steady-state cells growing in the logarithmic phase of growth, RNAP 
core enzyme amounts are estimated to be between 1,500 to 2,000 molecules per cell 




70 (RpoD) “housekeeping” sigma factor 
σ
S (RpoS) general stress/stationary phase sigma factor 
σ
54 (RpoN) nitrogen limitation sigma factor 
σ
32 (RpoH) heat shock sigma factor 
σ
28 (RpoF) flagellar synthesis sigma factor 
σ
24 (RpoE) 
extracytoplasmic (cell envelope) assembly and 
maintenance sigma factor 
σ




phase [22, 25, 26].   It has been shown that a percentage of sigma factors are released 
from the core enzyme during elongation after every round of transcription to be 
exchanged with a new one [27].   Binding affinity is another determinant in sigma 
factor competition with σ70 possessing the strongest binding to the core enzyme 
followed by σN, σF, σE/σFecI,  σHand σS with decreasing affinities [23].  This is 
particularly fascinating considering levels of σS increase to 30% of σ70 in stationary 
phase, while the latter and σN  remain static [26, 28].  Clearly there are other 
dynamics contributing to the fluctuation of sigma factor binding to core polymerase 
depending on the environment.  The emergence of unpredictable conditions is 
perceived by several intracellular signals that sense the nutritional quality of the 
environment, such as the alarmone guanosine 3’5’- bispyrophosphate (ppGpp) [29-
32].  Such transduction signals elicit an enhanced affinity of a particular sigma factor 
for the available RNA polymerase by providing a selective advantage for that factor 
or allowing several sigma factors to work in concert to shift their relative 
competitiveness [27, 33, 34]. 
Being the primary factors, much of the shift between sigma factors occurs 
between σS and σ70, occasionally working in tandem with one of the other five 
alternative factors.  This is due to the fact that during a cell’s life cycl  it must 
constantly trade-off between growth/reproduction and maintenance/survival [35] 
which are predominantly regulated by the complementary roles of these two sigma 
factors.   In vitro, both factors are able to transcribe many of the same genes, 
indicating the presence of other signals occurring in vivo to account for variable gene 




holoenzyme  is also supported by the protein Crl [37, 38].  Aside from the simple 
abundance of RNAP core enzyme complex there are other features that contribute to 
the switch between σS and σ70 selectivity [39, 40].  Another feature implicated is the 
promoter consensus sequences surrounding the -35 and -10 upstream regions.  σS and 
σ
70 have different preferences for the nucleotide at position -13.  Cytosine in this 
position is highly conserved for σS promoters and directly interacts with K173 residue 
found in σS.  σ70  possess glutamate in this position creating a preference for guanine 
at -13 [41].  The superhelicity of the DNA template is significant as σ70 hows high 
efficiency transcription of supercoiled DNA while σS transcribes more relaxed DNA 
[42] .   Rsd is a protein that interacts with σ70 inhibiting transcription of its dependent 
genes and is therefore referred to as an anti-sigma factor [43, 44].   The 6S RNA 
operates similarly to Rsd by interacting with σ70-holoenzyme reducing its activity and 
promoting the utilization of σS [45] and increased stress resistance and survival [46].  
Other aspects include the fact that σS tolerates degenerate promoter sequences and 
















































Figure 1 – The RNA polymerase holoenzyme – A) The sigma factor directs the RNAP 
holoenzyme to specific promoters. B) The holoenzyme then binds to the promoter and 
mRNA transcription is initiated.  After elongation begins, the sigma factor falls off to bind to 














RpoS- stationary phase and the general stress response 
Cells experience proliferation and reproduction during the exponential phase 
in a nutrient rich, stress free environment that supports growth.  When nutrients 
become exhausted or when concentrations of toxic waste products becomes too high, 
cells cease reproducing and growing and enter into the stationary phase.  In stationary 
phase, cell resources divide and some shift from proliferation and production to 
survival and maintenance, also the characteristic of a stress response. This phase does 
not specifically describe a fixed physiological state and is reversible if th  stress can 
be combated or nutrient levels replenished [47]. 
In E. coli the general stress response is under the control of the master 
regulator, σS (RpoS) which renders cells broadly resistant [9, 48].  RpoS induction is 
a response cells transiently resort to by inducing a more economical system during 
times of perceived stress or in anticipation of stress.  This may explain why during 
exponential phase undetectable amounts of σS are present in the cell, though there an 
abundant amount of rpoS mRNA is present, whose transcriptional induction starts in 
mid-exponential phase.  When stationary phase is reached, the cells are experiencing 
some of the same characteristics that designate a stress response (e.g. nutri nt 
limitation) and increased rpoS mRNA translation ensues [49].  This presence of σS 
can be further augmented by the simultaneous stabilization of σS already available in 
the cell.  Upon entry into the stationary phase the amount of σS is about 30% the 
amount of σ70 [26].  As many as 500 genes have been shown to be controlled by 
RpoS, in exponential phase, stationary phase or both, include genes required for DNA 




biosynthesis, cell structure, energy metabolism, amino acid biosynthesis and 
metabolism, enzymes involved in the TCA cycle, transport proteins and virulence 
factors in pathogenicity [7, 47, 50-55]. 
RpoS is intricately regulated on all levels, mRNA synthesis, stability and 
translation and proteolysis, though most occurs post-transcriptionally [48, 56].  At the
post-transcriptional level, RpoS mRNA is controlled by at least four small noncoding 
RNAs and several proteins (e.g. LeuO, HF-I, and HU) which target its secondary 
structure [57, 58].  Protein stability is controlled by the ClpXP protease, which is 
recruited by the response regulator, RssB and the chaperonin, DnaK [59, 60].  
Phosphorylated RssB acts as a proteolytic recognition factor directly interacting with 
RpoS, delivering it to the ClpXP protease degradation complex which recognizes 20 
amino acids between residues 170 and 190.  No other protein factor is required for 
RpoS degradation [61].  During exponential growth at 37oC, RpoS is extremely 
unstable with a half life of less than two minutes.  Entry into the stationary phase
increases the half life to 30 minutes.  RpoS mutants show decreased survival during 
stasis and stress [62, 63].  Though there is a divergence in genomes across specie, 
the RpoS regulon still has similar functions in many proteobacteria [64]. 
 
Small non-coding RNAs 
Environmental cues are sensed and responded to by untranslated specific 
small RNAs (sRNA) resulting in changes in both mRNA and protein synthesis and 
stability [65] .  These sRNAs do not encode for proteins and function solely as 
regulatory RNAs [66].   Sizes for small RNAs vary dramatically, generally between 




RNAs differ in the number of secondary structures that can be achieved, as well.  
Many of the earliest known sRNAs were discovered unexpectedly by analysis of 
RNA transcripts observed during studies of E. coli promoter regions and mutations of 
known neighboring genes, identified by their association with proteins of interest or 
resulting phenotypes of multicopy plasmids.  Until the beginning of this decade only 
13 sRNAs had actually been characterized [67].  Since then, systematic 
computational, microarray and cloning based screens have been performed based on 
criteria deduced from the previously characterized sRNAs  including conserved 
intergenic regions, rho-independent terminators and co-immunoprecipitation with Hfq 
[68, 69], an RNA chaperone protein.  Noncoding RNA regulation has been found to 
extend to several species including eukaryotic microRNAs (miRNAs) and small 
interfering RNAs (siRNAs), however, the term small RNA is usually reserved for 
small bacterial noncoding RNA.   
While a couple noncoding RNAs are essential to E. coli serving in structural 
or quality control capacities, most are regulators synthesized under specific 
conditions to execute a specific action for a limited time period.  Such sRNAs either 
bind a protein, altering its activity, or a target mRNA, functioning as an antisense 
regulator and affecting the translation or stability of that target.  Cis-acting sRNAs are 
encoded on the opposite strand of their targets and exhibit complete complementarity 
to this one target transcript.  Most of these sRNAs are expressed from a plasmid and 
control cell copy number [70].  Conversely, trans-acting sRNAs, which constitute the 
majority of sRNAs, are encoded at other loci in the genome, are only partially 




encoded adjacent to the gene that regulates their transcription.  Most of this regulation 
is negative, resulting in repression by inhibiting mRNA translation, degradation by 
RNase E/RNase III,  or both,  requiring binding to the Hfq protein to facilitate the 
interaction with the mRNA target(s) [71].   This is accomplished through binding the 
5’-untranslated region (UTR) region, sequestering the ribosomal binding site (RBS)
or base pairing within the first five codons of the coding region, preventing ribosomal 
binding or increasing stability of its target [72, 73].   There is only one sRNA known 
to bind the 3’-UTR of its target, GadY [74].  Even more interesting is the fact that 
though base pairing only needs to occur between a small group of nucleotides (about 






Figure 2 – The predicted secondary mRNA structure of RpoS. The extended 5’-
UTR region of the rpoS mRNA forms a self inhibitory hairpin loop that obstructs the 






Approximately 30 sRNAs in E. coli operate with Hfq at the interface between 
them and their specific target(s) [77].  Initially Hfq protein was identified as a 
bacterial host factor for RNA phage Qβ replication but was later found to be a 
requirement for the function of several sRNAs [78-80].  This protein is also denote 
host factor I (HF-I).  Hfq is a conserved bacterial homologue protein much like Sm 
and Sm-like proteins in eukaryotic systems [81].  It tightly binds RNA but does not 
have a precise target sequence, though it appears to bind unstructured AU- rich 
sequences.  This AU-rich element was recently confirmed to be necessary [82-85].  
Estimations of the quantity of Hfq proteins have been calculated to be between 
30,000-60,000 molecules per cell [86].  Many cellular processes are affected by Hfq 
including stimulation of RNA-RNA association and RNA binding and stabilization of 
sRNAs [85].  Recent studies have suggested that Hfq may stimulate the binding of 
both RNAs simultaneously in RNA-RNA interactions [87].   Hfq interacts with many 
small RNA species exhibiting chaperone activity, controlling regulation and 
stabilizing sRNA transcripts by protection from RNase E cleavage [77, 88].   Binding 
to Hfq by sRNAs occurs 1:1 stoichiometrically [89].  Hfq is only required to facilit te 
the formation of the sRNA-mRNA complex and has been predicted to cycle by 
transiently associating with several competitors at the same time, where one sRNA 
eventually displaces the other causing it to dissociate, effectively changing sites [90].   
This interaction may also be influenced by salt concentrations [91].   Cycling allows 
Hfq to interact with all of its potential targets, however, other studies suggest that Hfq 




for activity by others [92].  Dynamic competition supports better alignment of Hfq 
and its target RNA and consequent annealing efficiency [93].  X-ray crystallography 
has confirmed the structures and two binding surfaces of Hfq in E. coli [79, 94], 
Staphylococcus aureus and Pseudomonas aeroginosa. 
 
RpoS and small RNAs 
The secondary structure of rpoS mRNA, together with small regulatory 
RNAs, control translation under different stress conditions.  The inhibitory secondary 
structure of rpoS mRNA is comprised of a hairpin created by an extended 5’- 
untranslated region which occludes the ribosomal binding site and prevents 
translation.  The predicted Mfold secondary structure as reported by Worhunsky and 
colleagues is shown in Figure 2 [95].  To date there are at least four small RNAs that 
have been shown to interfere with this inhibitory leader region disrupting its 
regulatory structure: three activators, DsrA, RprA, and ArcZ and one repressor OxyS 
[85, 96].  Low temperature and cell surface stress stimulate RpoS translation 
respectively mediated by DsrA and RprA.   Very recently, ArcZ was shown to play a 
role sensing aerobic and anaerobic conditions.   While these three sRNAs sense 
different environmental conditions, they still trigger RpoS translation in the same w y 
(Figure 3).  In response to oxidative shock, OxyS represses RpoS translation.  There 
is mounting evidence that there exist several more sRNAs that interact with RpoS 
[68, 85].  These sRNAs are all members of the trans-acting group of sRNAs with an 
Hfq requirement, though DsrA establishes comparable tight binding to the RpoS 
header region even in an hfq mutant [85].  Currently, RpoS is the only known case 




cases may exist, reinforcing the idea of its role as an intracellular adaptor for many 
microorganisms.  The RpoS paradigm is thus far the best illustration of the intricacies 






Figure 3– RpoS mode of activation by sRNAs. The inhibitory structure of RpoS is 
relieved by the interaction of the 5’-UTR leader region with an activ ting sRNA and 
Hfq resulting in translation. The region complementary to activating sRNAs is shown 






One of the first small untranslated RNAs, DsrA (downstream region A), an 87 
nucleotide sRNA, was discovered downstream of the capsular polysaccharide 
controlling gene, rcsA [97].  DsrA was later found to be essential for stimulating rpoS 
mRNA translation at low temperature (30oC and below) during the exponential phase 
of growth [98].  Synthesis of DsrA is under temperature control. Temperature affects 
both the synthesis and stability of DsrA, leading to thermoregulation of rpoS 
translation [99].    Transcription profiling using DNA arrays revealed multiple acid 
resistance genes when DsrA is overexpressed [100].   DsrA also has a second target, 
overcoming H-NS mediated transcriptional silencing of genes, including rcsA which 
positively regulates capsule synthesis by negatively affecting transcription.  These 
activities are independent with the rpoS complementary region residing in the first 
stem loop of the secondary structure and the hns complementary section is located in 
the second stem loop.  The third predicted stem loop is the transcription terminator of 
dsrA (Figure 4A) [101-103].  The predicted points of base pairing with rpoS, as 
depicted by Mandin and colleagues, are shown in Figure 5B [104]. 
 As an early detected sRNA, DsrA is also one of the most studied and has 
largely been the sRNA prototype for studying the interplay between small RNAs and 
their molecular mechanism.  At least two functions for Hfq in the process of DsrA-
mediated regulation of RpoS mRNA have been proposed.  One role appears to be to 
induce the conformational changes needed by DsrA to interact with the rpoS mRNA 
header region, while the second suggests it accelerates DsrA annealing to the same 




rapidly degraded in its absence, by redirecting RNase III cleavage [106].   There are 
conflicting viewpoints on whether DsrA interacts with ribosomal protein S1, which 
binds to poly-U stretches and may enhance translation initiation [107]. 
 
RprA 
RprA, RpoS regulating, RNA is a 105 nucleotide untranslated RNA 
uncovered in a screening for potential suppressors of d rA mutants.  Like DsrA, RprA 
alters the secondary structure in the rpoS mRNA leader sequence activating RpoS 
translation in response to osmolarity and cell envelope stress [108].  RprA does not 
possess all the same points of complementarity as those involved in DsrA couplings, 
however, both predicted structures have pairing requirements within the same are of 
the rpoS mRNA regulatory region (Figure 5C) [109].  Expression of RprA is 
activated via the RcsC/YojN/RcsB phosphorelay system and specifically by RcsB 
[110].  The phosphorelay is activated by solid surfaces and regulates genes associated 
with the cell membrane or cell surface, many which are speculated to participate in 
biofilm formation [111].  RprA levels increase in stationary phase but this increase is 












Figure 4 – The predicted secondary mRNA structures of DsrA and OxyS.  A) DsrA has 
three stem loops.  The first loop interacts with RpoS, the second loop interacts with the global 
transcription regulator HNS, and the third loop is the transcription terminator. B) OxyS has 
three stem loops binding Hfq between loops two and three.  The exact mechanism of target 
interaction is still unknown. 
 
ArcZ 
ArcZ, formerly identified as RyhA and SraH, was identified in two separate genomic 
searches for small RNAs in E. coli [68].     The name was changed to ArcZ because it 
was found to be encoded concurrently with arcB which is involved in the growth 
transition from aerobic to anaerobic in E. coli [104] .  It is well conserved and can be 
processed to a truncated form [112].  The interaction of its secondary mRNA 






shown to affect many genes, including a methyl accepting chemotaxis protein 






















Figure 5– Pairing of activating sRNAs to RpoS regulatory hairpin structure.  A) ArcZ  
B) DsrA and C) RprA.  
 
Oxys 
OxyS, or oxidative stress, RNA is a109 nucleotide untranslated RNA transcriptionally 
regulated by OxyR in response to oxidative stress.   OxyS behaves as a global 
regulator both repressing and activating the expression of multiple genes, as well as,
an antimutator protecting cells against DNA damage [116].  Translation of two target 
genes is repressed via OxyS regulation: fhlA and rpoS.   FhlA activates formate 
hydrogenase synthesis in the presence of formate which can lead to H2O2 - induced 
damage in the company of metal cofactors.  OxyS also forms a predicted three loop 




inhibiting translation by interfering with ribosomal binding in two places [114], the 
mechanism of OxyS in the case of RpoS inhibition is still remains unclear [115].  
However, the role of OxyS has been proposed to be indirect by heavily binding Hfq, 
occupying the protein so that is unavailable to act on rp S mRNA [116].  This notion 
is further supported by suggesting this mode of action reduces the redundancy of 




When a gene transcript binds to target RNA in such a way as to promote the 
blocking or activation of ribosomes affecting translation to acclimatize to 
environmental fluctuations, this gene is considered a riboregulator.  Small RNAs
rapidly respond to response to diverse signals and modulate gene expression to 
accommodate versatile conditions qualifying them as riboregulators [102, 117, 118].  
This newly realized critical role for sRNAs in mediating gene expression has spurred 
a large effort to engineer this activity n vivo. 
Small RNAs make attractive engineering targets due to the simplicity of base 
pairing interactions and the wide variety of secondary structures possible [117, 119, 
120].  The concept of a modular engineered riboregulator system was successfully 
demonstrated by Isaacs et al. by applying knowledge of natural small RNA regulators 
and their target mRNAs [121].  The engineered regulators used an independently 
transcribed trans-activating small RNA that was able to bind a cis-repressing 
sequence in the 5’ untranslated region of the regulated gene.  The design of this 




a uracil base, N denotes any base, and R denotes a purine base (A or G)] motif of the 
loop sequence that has been shown to be important in the interactions of RNA in 
natural antisense systems [122].  This example and many others like it often engineer 
sequences inserted into the 5’UTR that promote the formation of aptamers for ligand 
binding or hammerhead ribozymes to create riboswitches.  While the use of antisense 
RNA has also become widespread [123], the use of engineering trans-acting switches 
is still relatively new idea.  This is largely due to the uncertainty of the actual signal 
transduction cascade of these RNA biosensors and their mode of action.  Use of such 
systems is also limited by the fact that while hundreds of trans-encoded small RNAs 
have been revealed still only a handful has identified targets. 
 
Advantages of using sRNA riboregulation 
While there have been several successful investigations on studying the effects of 
various controls on every level of RpoS regulation, sRNA offers some unique 
advantages to these other methods including but not limited to the following:  
• sRNAs expend less cellular energy to produce than proteins because 
they do not require translational resources 
• the small size of most sRNAs allows a rapid response to 
environmental stimuli 
• sRNAs are surprisingly stable and persist long enough to interact with 
their target transcripts 
• sRNAs that target translation provide a simple way to impose global 




• multiple sRNAs made under different conditions can regulate a single 
target 
• sRNA regulation removes the uncertainty of using base pairing 
techniques in conditions that spur gene mutations or when targeting 






Traditionally, metabolic engineering targets proteins or enzymes for 
modification to affect cellular regulation.  Due to its polymorphic nature this 
approach would be limiting for controlling RpoS gene expression profiles due to the 
uncertainty of the nature of the particular RpoS gene that may be present in the 
system.    The obvious advantage to using small RNA riboregulation is that the RpoS 
genetic profile can potentially always be influenced regardless of genetic makeup. 
RpoS regulation embodies a prime example of the potential magnitude of the 
extent of sRNA modulation.  In this instance at least four such sRNA riboregulators 
are involved.  DsrA, RprA, ArcZ and OxyS are able to sense stressors in the 
environment resulting in an increase/decrease in RpoS translation and RpoS-
dependent genes to enhance cellular fitness and survival.  This study attempted to 
gain a better understanding of the role of small RNAs serving as riboregulators in he 
control of σS function on E. coli cellular behavior.  Overexpression of small RNAs is 
typically used to investigate its function.  We attempted to create an inducible smal  




alterations in a desired E. coli strain by varying the amounts of inducer. We then 
examined the feasibility of exploiting the properties of these small RNAs in an
interchangeable inducible riboregulatory platform, where different sRNAs can be 
used to influence diverse gene expression profiles in several strains of E. coli.  This 
concept was explored through the analyses of both immediate gene transcription 
modulation and downstream phenotypic effects of the riboregulation of Escherichia 
coli σS, or RpoS.   
 Globally, we hypothesize that the modulation of activation or 
repression of rpoS mRNA translation on a molecular level via small RNA 
riboregulators will permit the effective exploitation of the desired characte istics of 
the cellular phenotypes conferred by σS.  More specifically our research sought to 
acquire a better understanding of the prospective of engineered small RNA 
riboregulation through the following objectives: 
1) Create an arabinose inducible promoter system for the RpoS activator, 
RprA, and repressor, OxyS, which effectively overexpresses the specific 
sRNA and increases/attenuates RpoS levels in various Escherichia coli 
strains. 
2) Analyze whether the effect of positive modulation of RpoS translation in 
exponential phase results in a subsequent transcriptional up- or 
downregulation of confirmed RpoS-dependent genes, potentially 





3) Examine if the positive/negative modulation of RpoS provides a selective 
advantage to σ70-dependent genes which support growth by means of 
either cross-protection or loss of some RpoS function. 
4) Examine if the positive/negative modulation of RpoS results in an ensuing 
decrease in σS -dependent genes and a diminished capacity for stress 
protection, leaving cells less equipped to adapt and survive, hampering or 
promoting the cells ability to adopt protective states. 
5) Investigate the downstream phenotypic results of the aforementioned 
effects on differences in motility, biofilm formation and heterologous 








Chapter 2: Characterization of RpoS Genetic Profiles and Regulatory 
Effects as a Consequence of Overexpression from RprA Activation and 





 The ability to isolate microbes has undoubtedly allowed scientists to 
effectively characterize microbial behavior for decades.  The additional challenge has 
often been to interpret these findings in relation to the larger environmental 
architecture.  This simply translates to the fact that microbes exist in heterog neous 
populations and surroundings that obviously influence their function.  The ability to 
respond to dynamic surroundings renders bacteria remarkably adaptive and resilient.  
Escherichia coli are able to thrive and subsist in a multitude of environments by 
altering gene expression.  This shifting environment is monitored by the cell which
requires constant competition among the seven sigma factors for limited amounts of 
core RNA polymerase for transcription [22, 23]. 
RpoS is the master regulator of the general stress response [9, 48] and 
involved in the regulation of hundreds of genes throughout the cell cycle required for 
DNA damage, shifts in nutrient composition, osmotic shock, chemotaxis and 
flagellum biosynthesis, cell structure, energy metabolism, amino acid biosyntheis 
and metabolism, enzymes involved in the tricarboxylic acid cycle (TCA) cycle, 
transport proteins and virulence factors in pathogenicity [7, 47, 50-55].  Considering 
the vital role of RpoS in cell survival, the ability to modulate it, by hindering or 




pathways.  This could have extensive implications for global coordination of gene 
expression profiles and cellular behavior. 
Although RpoS plays an important role in regulating global gene expression 
for survival and adaptation to a wide range of stresses, many widely used E. coli 
laboratory strains carry  point mutations and deletions within the rpoS gene resulting 
in various levels of RpoS activity [124].   This can occur among stocks of different 
strains in different laboratories or between various strains of the same lineage b cause 
stored bacterial can be heterogeneous, contributing to strain variation particularly in 
RpoS function.  There are a number of sequence differences even in the three “wild-
type” K-12 strains.  RpoS also regulates many of the genes responsible for 
maintaining the fidelity of gene transcription, for example mutS and dinB (DNA 
Polymerase IV).   mutS is responsible for repairing DNA mismatches and dinB both 
generates spontaneous mutations at a higher rate than other replicative polymerases 
and plays a role in adaptive mutations [125-130].  Such genes make it possible for the 
cell to produce variants that survive.  One of the most common mutations is in codon 
33, which results in an amber stop codon (CAG goes to TAG) and premature 
termination of RpoS synthesis [131, 132].    It has been demonstrated that a secondary 
translational initiation region (STIR) exists in the rpoS gene that still confers a 
survival advantage by allowing translation of truncated forms [133].  This 
phenomenon has been explained by the fact that bacteria consistently try to balance
between self-protection and nutritional capability, the SPANC balance, for an 
advantage in a given environmental condition, including selective loss of RpoS 




allelic variations, provides some challenges if scientists are to be able to exhibit an 
element of control over its regulation.  However, it is possible that targeting this gene 
for modulation by sRNAs may be a solution. 
Traditionally, genetically engineering factors to influence the control of 
metabolic pathways has involved overexpression or alteration of proteins that confer 
the desired phenotype [135].  A majority of cellular engineering strategies us ng RNA 
have been in eukaryotic systems, but more bacterial systems have surfaced.  RNA 
participates in the modulation of almost every aspect of cell metabolism through a 
wide range of regulatory functions, as well as, serves as a biosensor to facilitate the 
direction of bacterial gene expression.   This fact, coupled with its modularity, simple 
mode of action and diversity of structure and function, makes RNA a particularly 
attractive tool for genetic engineering design [117, 136].   Thus far one of the most 
popular employments of genetically engineered RNA in bacteria has come in the 
form of antisense technology.  Antisense RNA has actually been effective in 
downregulating RpoS itself [123, 137, 138].   Antisense agents can both 
downregulate targets without disrupting the genome and transiently inhibit genes that 
are lethal as knockouts.  Other systems use riboswitches comprised of ribozymes and 
ligand-aptamer couplings which have been used successfully for many types of 
regulation from transcription termination and translation initiation to splicing in 
eukaryotes [139] with great specificity.  These systems are usually confined to 
controlling gene expression via a single mechanism.  Trans-encode sRNAs can not 




global regulators.   We envision the use of these biosensors as a type of switch to be 
used to control RpoS regulation.   
 This research attempts to circumvent the uncertainty associated with the 
requirement of a precursor stimulus by directly exciting RpoS translation with sRNAs 
overexpressed from an inducible platform.  We have engineered both an activator, 
RprA, and a repressor, OxyS, to be expressed from a variable arabinose induced 
promoter (Figure 6).  This engineered platform will not only serve to examine the 
changed gene expression profiles but to attempt to observe the direct alteration of 




Figure 6 – sRNA riboregulatory platform. Arabinose induced overexpression of 
different sRNAs from a plasmid will interact with RpoS, either activating or 




Materials and Methods 
Bacterial Strains and growth conditions 
Bacterial strains used are included in Table 2.  Overnight cell cultures wer  
inoculated in 100 mL of Luria-Bertani broth (LB) to an OD600 0.01 in a 250 mL flask.  
All 100 mL experimental cultures were prepared from one larger inoculated OD600




0.3 at which point culture volumes equivalent to1 mL at an OD600  2 were collected 
for protein samples and two 2 mL samples were collected for total RNA.  Cultures 
were then induced for RprA sRNA transcription with the appropriate concentration of 
L-arabinose (0-2%).  RNA samples were collected 15 minutes post-induction and 
both RNA and protein samples were collected at 30 minutes, one and three hours 
post-induction. Cultures were supplemented with ampicillin (50 µg/µL) when needed. 
 
Table 2 – Bacterial strains used in this study 
     Strain                                       Genotype                                                      Source 
Top10 
F–, mcrA, ∆(mrr-hsdRMS-mcrBC), φ80lacZ∆M15, ∆lacX74, 
deoR, recA1, araD139,  
∆(ara, leu)7697, galU, galK, rpsL(strr), endA1, nupG 
Invitrogen 
MG1655 F- λ- ilvG- rfb-50 rph-1 ATCC 
W3110 F- λ- rph-1 INV(rrnD, rrnE) Laboratory stock 
MC4100 F
− araD139∆(argF-lac)U169 rspL150 relA1 flbB5301 fruA25 
deoC1 ptsF25 
UMCP Molecular Biology 
Department laboratory stock 
 
 
Small RNA and RpoS plasmid construction 
The construction of pRprA was as follows.  The rprA gene was cloned from 
K-12 genomic DNA with NcoI and HindIII restriction enzyme sites using the 
following PCR primers: RprA_For (5’- TCG CCC ATG GAC GGT TAT AAA TCA 
AC- 3’) and RprA_Rev (5’- ACT TAA GCT TAA AAA AAG CCC ATC GT- 3’).  
This product was then purified, digested with the appropriate enzymes and ligated 
into the pBADHisA vector (Invitrogen) in the corresponding sites, removing the N-
terminal polyhistidine (6xHis) tag, immediately downstream of the araBAD 




primers: OxyS_For (5’- ATA CCA TGG AAA CGG AGC GGC AC- 3’) and 
OxyS_Rev (5’- TAA TAA GCT TAG CGG ATC CTG GAG A - 3’).   pRpoS was 
constructed similarly except the rpoS gene was placed immediately after the 
polyhistidine tag by replacing the NcoI restriction enzyme site with NdeI using the 
following primer set: RpoS_For (5’- ACC GCT AGC ATG AGT CAG AAT ACG - 
3’) and RpoS_Rev (5’- ATT AAG CTT TTC ACG GGT GAG GCC - 3’) (Figure 7).  
All primers were from Integrated DNA Technologies (Coralville, IA).  DNA 
sequencing of all constructs was performed to verify integrity at the DNA core 
facility of the Institute for Bioscience and Biotechnology Research (University of 




Figure 7 – pRprA, pRpoS and pOxyS expression vectors. The small RNA genes, 
rprA and oxyS were cloned between the NcoI and HindII restriction enzyme sites, 
directly after the arabinose induced pBAD promoter.  The rpoS gene was cloned after 





RNA isolation, cDNA cloning and semi-quantitative RT-PCR 
A 2 mL sample was collected at the indicated times and spun down at 10 x g 
for five minutes.  The pellets were resuspended in Trizol Reagent (Invitrogen) and 
frozen at -20oC until needed.  Total RNA was isolated per the manufacturer’s 
instructions and the RNA pellet was resuspended in 50 µL of RNase/DNase free 
water (VWR).  RNA concentration was quantified using a NanoDrop 
Spectrophotometer (ThermoScientific).  Samples were treated with DNase I, 
Amplification Grade (Invitrogen).  First strand templates of each target gene were 
synthesized from 500 ng of total mRNA using random hexamer primers and the 
Superscript RT III kit (Invitrogen).   PCR for all genes was performed for 27 cycles 
using Accuprime Taq Polymerase (Invitrogen).   16S was used as a control for all 
samples.  PCR products were visualized on 1% agarose gels and analyzed using the 
AlphaImager®HP System and accompanying software from AlphaInnotech (Santa 
Clara, CA).  Primers for all of the genes tested are listed in Table 3.   
SDS-PAGE and Western blotting 
Whole cell pellet samples equivalent to 1mL at OD600 2 were collected for all 
cultures to be compared at the indicated time points, spun down at 10,000 x g for five 
minutes and stored at -20oC until needed.  The pellets were thawed on ice and 
resuspended in SDS-PAGE sample loading buffer (0.5 M Tris-HCL (pH 6.8), 10% 
glycerol, 5% sodium dodecyl sulfate (SDS), 5% β-mercaptoethanol, and 0.25% 
bromophenol blue).  The samples were heated to 100oC for five minutes and 
vortexed.  Ten microliter samples were loaded into a 12.5% polyacrylamide gel and 




system.  Gels were then incubated for 30 minutes in Bjerrum and Schafer-Nielsen 
(BSN) buffer and transferred to nitrocellulose membranes using a Trans-Blot SD 
Semi-Dry transfer cell (BioRad) for one hour at 100 mA and then at 20 V for 15 
minutes.  RpoS protein level was detected by 1:1000 dilution of a monoclonal σS 
primary antibody (NeoClone Biotechnology, Madison, WI).   Goat-anti-mouse was 
diluted 1:5000 for the secondary antibody (Sigma-Aldrich, St. Louis, MO).  The blots 
were developed colorometrically for ~30 minutes and the band intensity levels wer 
analyzed by Image J Software (NIH). 
 
Table 3 – Oligonucleotides used for semi-quantitative RT-PCR 
Name  Sequence (5’ to 3’) 
16S_For AGC GCA ACC CTT ATC CTT TGT TGC 
16S_Rev TCG CGA GGT CGC TTC TCT TTG TAT 
bolA_For AAG CTA TCG TCA CAA TGT CCC AGC 
bolA_Rev TAA GTA TGC AGA GCC AGC GCA TGA 
flhD_For CAT TCA GCA AGC GTG TTG AGA GCA 
flhD_Rev CAT TCA GCA AGC GTG TTG AGA GCA 
rssB_For TAA TTC GCG CGT TGA GGA AGA GGA 
rssB_Rev CCG AAA GTG CGG CAA TAT CAA GCA 
ibpA_For CAT TGC TAT CGC TGT GGC TGG TTT 
ibpA_Rev ACC AGG TTA GCA CCA CGA ACA TGA 
pgaB_For TCG TGA AGC ACA TCG AGG AGG AAA 
pgaB_Rev TGA AGA ATT GGG AAG ACG CGG GTA 
rpoD_For AAA TAC ACC AAC CGT GGC TTG CAG 
rpoD_Rev AGG TTG CGT AGG TGG AGA ACT TGT 
ycdT_For GAA CAT TGC ACA TCG CGA TCC CTT 
ycdT_Rev TTT ATC ACC TGA TCG CCA ACC GGA 
Lon_For CCA AAC TGT GTC GCA AAG CGG TTA 





Samples equivalent to 1mL at OD600 1 were collected for all cultures.  Total 
RNA was isolated from the cultures using an RNeasy Mini kit (QIAGEN, Inc., 
Valencia, CA) according to the manufacturer's instructions. RNAprotect bacteria 
reagent (QIAGEN, Inc., Valencia, CA) was immediately added to the cultures o 
stabilize RNA before isolation. The RNase-free DNase set (QIAGEN, Inc., Valencia, 
CA) was used for on-column DNase digestion to remove residual DNA.   Gene 
expression was analyzed using a 4x72K (4 x 72,000 probes) NimbleGen array 
(NimbleGen, MadisonWI).  cDNA was created from 10 µg total RNA using the 
SuperScript Double-Stranded cDNA synthesis Kit (Invitrogen).  The cDNA was 
labeled using NimbleGen One-Color DNA Labeling Kit and hybridized to an arry 
using the NimbleGen hybridization system.  The array was then washed, dried and 




Results and Discussion 
 
pRprA overexpression of rprA transcript levels and corresponding RpoS protein 
levels 
 
 The rprA gene was put under the arabinose inducible araBAD promoter.  This 
vector is capable of inducing the gene of interest over a wide range of inducer 
concentrations [140].  We were interested in adding another layer of control by 
potentially varying the amount of transcript produced.  Most chemical inducer 
systems have an all or nothing level of induction due to initial limitations of 




slightly varied.  Cells were grown at 37oC in LB broth with ampicillin when 
necessary.  At OD6000.3 cultures were induced with the indicated final arabinose 
concentrations. Samples were taken and total RNA was isolated.  Cultures were test d 
and their corresponding RprA RNA levels by semi-quantitative RT-PCR were 
visualized on a 1% agarose gel. Representative gels are shown in Figure 8.  Each 
experiment included a control with no plasmid (Top10), two controls containing an 
empty pBADHisA vector (one induced with 0.2% arabinose) to test for plasmid 
effects, and five containing the pRprA vector.  Experiments were evaluated for the 
effect of arabinose percentage (0%, 0.002%, 0.02%, 0.2% and 2%) on overexpression 
of RprA RNA.  At 15 minutes after induction, the levels of RprA RNA are present 
and do slightly vary across the range of concentrations tested, even in the uninduced 
pRprA culture (Figure 8A).  This difference is no longer seen by 30 minutes and all 
levels are similar except for the uninduced culture, which has a hardly discernable 
amount (Figure 8B).  There are still levels of RprA detectable even as late as 1 hour 
post-induction indicating the transcripts appear to be quite stable over a long period 
of time (Figure 8C).   This is unexpected as induction is normally a transient event, 
initiated quickly and subsiding within the hour.  This result can possibly be explained 
by the fact that the Top10 strain contains an araBAD deletion, meaning arabinose will 
not be metabolized by this strain, therefore remaining available as inducer for the 
vector.  It has also been shown that RprA levels can increase in stationary phase in an 
RpoS-independent manner.  This may also explain the persistence of RprA RNA.   As 









































Figure 8 –RT-PCR results for RprA RNA overexpression in Top10pRprA cells 
in response to arabinose. Top10 was transformed with pRprA (pBAD-rprA) or a 
vector control (pBADHisA).  Cells were grown at 37oC in LB with ampicillin (50 
µg/µL) when required. A control with no vector was also grown. At OD6000.3 
cultures were induced with the indicated final arabinose concentrations. Samples 
were taken, total RNA was isolated and semi-quantitative RT-PCR was perform d.  
RprA RNA levels were analyzed at A) 15 minutes, B) 30 minutes and C) 1 hour post-
induction (HPI). 16S transcript levels were used as a control. Bands were visualized on 




 Cultures were also evaluated for a corresponding subsequent level of RpoS 
protein.  Whole cell protein samples were collected and separated by SDS-PAGE and 
probed with σS antibody for Western blot analysis. Representative Western blots for 
each time point are shown in Figure 9.  All band intensities were normalized to the 
value of the Top10 control at the respective time point.  As expected in early 
exponential phase, the pre-induced cultures contain similar amounts of RpoS protein.  
By 30 minutes, the pRprA cultures induced with 0.002%, 0.02%, and 0.2% arabinose 
expressed RpoS protein levels at least twice as high as the control cultures.   The 
uninduced and 2% cultures are comparable to the controls and the induced (0.2%) 
pBAD vector is actually half the amount of the control.  This plasmid would be 
producing a very small nonsense transcript upon arabinose addition.  It is possible this 
caused a different stress response and the coincident upregulation of another sigma 
factor in this culture, such as σ32.  σ32 is responsible for the heat shock response and 
transcribes chaperone proteins and proteases that help address an acute stress. By on  
hour post- induction, the protein levels in all of the pRprA induced cultures increase 
to ~3 fold the amount in the Top10 control.  The protein levels in all the control 
cultures, as well as, the uninduced pRprA culture remain relatively consistent for all 
time points.  All cultures expressed similar levels of RpoS by three hours post-
induction.  This result suggests the pRprA overexpression system can both effectively 
overexpress RprA and that this RNA expression is enough to positively modulate 













Figure 9 – RpoS Western blot analysis of Top10pRprA.  Cells were grown at 37oC 
in LB.  At OD6000.3 cultures were induced with the indicated final arabinose 
concentrations. Whole cell protein samples were taken at the indicated time points. 
Samples were resuspended in protein loading buffer.  Ten microliter samples were 
used for SDS-PAGE and Western blotting.  Representative Western blots for the 
samples are shown (top).  Bands from the Western blot were quantified using Image J 
software and normalized against the Top10 control sample for each respective time 
point (bottom).  Error bars represent the standard of deviation for two replicates each 





Downstream effects on RpoS-dependent genes 
 The pRprA system was shown to effectively overexpress RprA RNA which 
led to increased RpoS protein levels. This, however, does not automatically mean this 
system translates into active RpoS control of downstream genes.  To test this, we
performed RT-PCR for two genes known to be RpoS-dependent.  The first is bolA, a 
cell morphology gene that protects the cell in stationary phase and during cellular 
stress, resulting in a smaller ovoid shape [141]. The second is flhD, which is part of 
the flhDC regulon that controls flagellar synthesis and ultimately cell motility and 
chemotaxis [142].  These genes are positively and negatively regulated by RpoS 
respectively.  Figure 10A reveals no obvious RpoS-dependent bolA regulation with 
respect to the RprA overexpression system at 15 minutes and at 30 minutes.  The 
level of bolA transcripts seems fairly similar across all the cultures, except for a few
fluctuations in the 0.002% and 0.2% pRprA cultures.  Conversely, the system did 
seem to have an effect on flhD transcript levels at 15 and 30 minutes in all of the 
pRprA induced cultures (Figure 10B).  flhD transcript levels are markedly lower in 
these cultures and at 15 minutes this downregulation seems to increase modestly as 
arabinose concentration increases.  At 30 minutes, there is no pronounced difference 
across the pRprA induced cultures.  At both time points, the uninduced pRprA culture 
was similar to the controls, suggesting arabinose induction is necessary to affec  this 
gene.  This also implies that the increase in RpoS protein levels does correspond to 
the regulation of at least one identified RpoS-dependent genes, flhD.  The 
complicated level of control of RpoS means that the gene expression profile for RpoS 




growth phase.  Considering the fact that we are expressing RpoS in the exponential 
phase, previously identified RpoS-dependent stationary phase genes need not be 
affected.  This is evident from the various DNA microarray reports on the gene 
expression profiles of rpoS mutants in different strains, phases and conditions  [7, 50, 
52, 55].  This also reveals the potential of using various sRNA overexpression 









































Figure 10 – bolA and flhD RT-PCR results for RprA RNA overexpression in 
Top10pRprA. A) bolA and B) flhD. Top10 was transformed with pRprA (pBAD-
rprA) or a vector control (pBADHisA).  Cells were grown at 37oC in LB with 
ampicillin (50 µg/µL) when required. A control with no vector was also grown. At 
OD6000.3 cultures were induced with the indicated final arabinose concentrations. 
Samples were taken, total RNA was isolated and semi-quantitative RT-PCR was 
performed. RNA transcript levels were analyzed at 15 minutes and 30 minutes. 16S 
transcript levels were used as a control. Bands were visualized on a 1% agarose gel using 


























































































































Figure 11 – RpoS Western blot analysis of Top10pRprA and Top10pRpoS.  Cells 
were grown at 37oC in LB.  At OD6000.3 cultures were induced with the indicated 
final arabinose concentrations. Whole cell protein samples were taken at the indicated 
time points. Samples were resuspended in protein loading buffer.  Ten microliter 
samples were used for SDS-PAGE and Western blotting.  Representative Western 
blots for the samples are shown (top).  Bands from the Western blot were quantified 
using Image J software and normalized against the Top10 control sample for each 
time point (bottom).  At 0.5 and 1 HPI, induced pRprA cultures have a twofold 
increase in RpoS protein levels over controls.  Induced pRpoS cultures have a ten- 
and fourfold increase in RpoS protein levels at the same time points, respectively. 
Error bars represent the standard of deviation for two replicates each for at least two 




pRprA mediated RpoS protein regulation compared to direct RpoS 
overexpression 
 In an effort to further validate the pRprA overexpression system, we wanted 
to compare this indirect RpoS regulation with regulation from directly overexpressed 
RpoS protein from the araBAD promoter.  Representative Western blots are shown in 
Figure 11.  It was not surprising to see that RpoS protein levels from the RpoS 
plasmid were almost 20 fold higher than the control cultures and 10 fold higher than 
pRprA cultures at 30 minutes, when induced by both 0.002% and 0.2% arabinose.  
This difference is decreased to about 7 fold and 3.5 fold higher at one hour post-
induction.  Employing a low concentration of arabinose (0.002%) and a higher 
concentration (0.2%) for induction in the pRprA system seemed to produce varying 
amounts of RpoS protein, slightly increasing.  This is not observed in the pRpoS 
system.  It is feasible that either this does not occur when RpoS is directly 
overexpressed, or the direct overexpression results in such a rapid accumulation of 
RpoS protein that the system becomes saturated and the difference in levels could not 
be visualized by 30 minutes after induction.  Uninduced pRprA and pRpoS cultures 
stayed at levels similar to the controls.  Induced pRprA cultures maintained the 2-fold 
increase over controls previously seen in earlier experiments.    
 We also wanted to observe if there was a difference in regulation of the bolA 
and flhD genes between the two systems.  We also chose to look at the rssB gene, 
which is required to direct RpoS to ClpX degradation.  It was possible that by 
increasing the levels of RpoS protein, the cell could respond by trying to promote 




and 12C, corresponding to b lA, flhD, and rssB, in that order.  For bolA transcription, 
again there is no real discernable difference in expression across all cultures at 15 
minutes.  However, both systems had a modest increase over the controls when 
induced by 30 minutes.  The case of flhD was very interesting in that pRpoS cultures 
had a slight increase in flhD levels when induced at 15 minutes post-induction.  This 
is in direct contrast to what was expected as this would indicate that direct 
overexpression of RpoS increased flagellar synthesis.  Even more, is the fact that by 
30 minutes induced pRprA cultures are significantly lower than controls and pRpoS 
cultures, which corresponds to the previous study.  Clearly in the area of motility, the 
two systems vary in regulation.  This could suggest that the direct overexpression of 
RpoS finds a selective advantage in keeping flagellar synthesis normal to modestly 
higher in the cell.   At 15 minutes, rssB did not reveal a particular trend across all the 
cultures.  Thirty minutes did again reveal very modest increases in the cultures 
containing pRprA and pRpoS over the controls.  This indicates that the 
overexpression of RpoS protein levels from both plasmids does not seem to result in 
such more rssB transcription than the control cultures. Still, this does not mean that 
RssB protein levels are not increased by higher levels of r sB mRNA translation or 


















Figure 12 – bolA, flhD and rssB RT-PCR results for RprA RNA overexpression 
in Top10pRprA and Top10pRpoS. A) bolA, B) flhD and C) rssB. Top10 was 
transformed with pRprA (pBAD-rprA) or a vector control (pBADHisA).  Cells were 
grown at 37oC in LB with ampicillin (50 µg/µL) when required. A control with no 
vector was also grown. At OD6000.3 cultures were induced with the indicated final 
arabinose concentrations. Samples were taken, total RNA was isolated and semi-
quantitative RT-PCR was performed. RNA transcript levels were analyzed at 15 
minutes and 30 minutes. 16S transcript levels were used as a control. Bands were 























The pRprA overexpression platform across strains 
 A key characteristic for this system was for it to be able to be efficient across 
various laboratory strains to study the effects.  To this end, pRprA was transformed 
into the strain, MG1655, which is widely considered the wild-type strain for K-12 E. 
coli.   As was done for Top10, the pRprA system was evaluated for its ability to 
overexpress the RprA RNA and affect subsequent RpoS protein levels.  MG1655 can 
metabolize arabinose as a carbon source, meaning all inducer did not solely go to the 
transcription of RprA RNA as in Top10. From Figures 13A and B, again we see that 
there are detectable amounts of RprA RNA with the addition of different amounts of 
inducer at both 15 minutes and 30 minutes.  There are very small levels in the 
uninduced pRprA cultures but these amounts are barely detectable when compared to 
the induced cultures.   Figure 14 displays representative Western blots of the RpoS 
protein levels expressed from the system.   It should be noted that there were no 
detectable pre-induction levels of RpoS protein in the wild type strain.  This supports 
the fact that rpoS transcription in wild-type strains does not begin until mid-log phase 
and up to that point rpoS is only present at basal levels. The levels seem to 
correspond to an increase in inducer with the 0.2% and 2% induced cultures being 
2fold higher in the first half hour.   By 1 HPI, these two cultures are at least three 
times as high as the control cultures.  One notable difference in this system is that the 
induced pBAD culture does show a response to arabinose addition with a modest 
increase in RpoS protein levels.   As noted previously, this system is producing 
amounts of nonsense transcript which could result in mild stress and therefore 




protein, except both cultures induced with 0.2% arabinose which have slightly less 
amounts. 
As done previously, the effect on downstream RpoS-dependent genes was 
also examined, for bolA (Figure 15A) and flhD (Figure 15B).   In this strain, bolA 
results were fairly similar across cultures at 15 and 30 minutes.   The trend for flhD at 
15 minutes is the same across all cultures except for the 2% induced pRprA culture 
which begins to show some decreasing transcript levels. At 30 minutes, the 0.02%, 
0.2% and 2% pRprA cultures all showed appreciable downregulation of flhD 
transcript levels when compared to control cultures. By 30 minutes post-induction, as 
in Top10, the pRprA system in MG1655 does show that the overexpression of RprA 
RNA results in downregulation of an RpoS-dependent gene, flhD.  Downregulation in 
Top10 was visible earlier, by 15 minutes post-induction, for induced pRprA cultures. 
Overall, this demonstrates that the pRprA expression system is not only viable in 









Figure 13 – RT-PCR results for RprA RNA overexpression in MG1655pRprA 
cells in response to arabinose. MG1655 was transformed with pRprA (pBAD-rprA) 
or a vector control (pBADHisA).  Cells were grown at 37oC in LB with ampicillin (50 
µg/µL) when required.  A control with no vector was also grown. At OD6000.3 
cultures were induced with the indicated final arabinose concentrations. Samples 
were taken, total RNA was isolated and semi-quantitative RT-PCR was perform d.  
RNA levels were analyzed at A) 15 minutes and B) 30 minutes. 16S transcript levels 
were used as a control. Bands were visualized on a 1% agarose gel using ethidium bromide 


















Figure 14 – RpoS Western blot analysis of MG1655pRprA.  Cells were grown at 
37oC in LB.  At OD6000.3 cultures were induced with the indicated final arabinose 
concentrations. Whole cell protein samples were taken at the indicated time points. 
Samples were resuspended in protein loading buffer.  Ten microliter samples were 
used for SDS-PAGE and Western blotting.  Representative Western blots for the 
samples are shown (top).  Bands from the Western blots were quantified using Image 
J software and normalized against the Top10 control sample for each time point 
(bottom).  Error bars represent the standard of deviation for two replicates each for t 




















































































































Figure 15 – bolA and flhD RT-PCR results for RprA RNA overexpression in 
MG1655pRprA. A) bolA and B) flhD. MG1655 was transformed with pRprA 
(pBAD-rprA) or a vector control (pBADHisA).  Cells were grown at 37oC in LB with 
ampicillin (50 µg/µL) when required.  A control with no vector was also grown. At 
OD6000.3 cultures were induced with the indicated final arabinose concentrations. 
Samples were taken, total RNA was isolated and semi-quantitative RT-PC was 
performed. RNA transcript levels were analyzed at 15 minutes and 30 minutes. 16S 
transcript levels were used as a control. Bands were visualized on a 1% agarose gel using 







DNA Microarray Results 
 The prior RT-PCR results indicated that there may be more genes that are 
affected unexpectedly in this system.   To further investigate a microarray was done 
to get a complete genetic profile.  We chose MG1655 as the host strain because of its 
wild- type status.   MG1655 is capable of metabolizing arabinose, so in a four plex 
array, we compared the wild type, an induced wild-type containing the pBAD vector 
to negate the effects of arabinose, an uninduced wild-type housing the pRprA vector, 
and an induced pRprA vector.  We chose an arabinose concentration of 0.2% because 
it has been shown to produce the high levels of RprA RNA from the araBAD 
promoter and because the previous data supported its efficacy for the pRprA system
in particular.  Samples equivalent to 1mL at an OD600 1 were collected at 15 minutes 
and processed as described in the Materials and Methods section.  Due to the 
extensive participation of RpoS in E. coli gene regulation many genes experienced 
significant fold changes, both negatively and positively.   This work is still ongoing 
but did provide us with several genes to further test by semi-quantitative RT-PC, 
ibpA, pgaB, ycdT, and lon.  Each of these genes experienced at least a four-fold 
difference in the pRprA induced cultures.  We also chose to compare each gene’s 
semi-quantitative RT-PCR results in MG1655 with the results acquired for the Top10 
strain. 
  The ibpA gene is a small heat shock protein that is associated with binding 
aggregated proteins and inclusion body formation upon recombinant protein 
production [143, 144].).  It is associated in an operon along with ibpB and both are 




temperature upshift and two of the most induced during biofilm formation [145].   
Mutants of ibpA and ibpB exhibit inhibited biofilm formation.  Both genes were 
recently found to be substrates of the ATP protease Lon [146].  The microarray 
reported a decrease in these two genes in the pRprA system in MG1655.  Analysis of 
pRprA in both Top10 and MG1655 using semi-quantitative RT-PCR displays 
interesting results.  In Top10 (Figure 16A), there is a modest upshift in cultures with 
arabinose concentrations of 0, 0.002 and 0.02%, all other cultures were similar and by 
30 minutes all the cultures were comparable.  On the other hand, in MG1655 (Figure 
16B) all the cultures with vectors expressed an increase at 15 minutes, with the 
0.02%-2% being slightly higher, except the uninduced pBAD culture.  This may 
make sense considering IbpA is a chaperone protein and while RprA is not a protein, 
it is still being overexpressed, perhaps creating a requirement for chaperone activity. 
The fact that this is in conflict with the microarray result will require further study.  
At 30 minutes, all of the induced pRprA cultures were like the wild-type with the 
pBAD and uninduced pRprA cultures modestly higher. 
 pgaB is part of a locus pgaABCD which is essential for the synthesis of a 
biofilm adhesin, PGA [147].  PgaB in particular is a predicted lipoprotein involved in 
the transfer of PGA across the outer membrane.  Expression of the operon is highest 
in stationary phase but it has also been shown to be expressed in response to NaCl 
and ethanol [148].  In both strains, pgaB was shown to be upregulated in the pRprA 
cultures especially at the 0.02%, 0.2% and 2% concentrations at both 15 minutes and 
30 minutes (Figures 17A and B).  In MG1655 at 30 minutes, the only detectable 




be some increase in the Top10 pBAD cultures indicating the possibility of plasmid 
effects on pgaB transcription however, this was dismissed when we compare this to 
the lack of transcription in the uninduced pRprA and the 0.002% induced pRprA 
cultures. Additionally, it was only a modest increase. Again, this plasmid produces a 
nonsense transcript which could lend to the emergence of secondary stress effects.  
Biofilm is usually produced in response to stressful conditions, in general.  In this 





































Figure 16 – ibpA RT-PCR results for RprA RNA overexpression in A) 
Top10pRprA and B) MG1655pRprA. Top10 was transformed with pRprA (pBAD-
rprA) or a vector control (pBADHisA).  Cells were grown at 37oC in LB with 
ampicillin (50 µg/µL) when required.  A control with no vector was also grown. At 
OD6000.3 cultures were induced with the indicated final arabinose concentrations. 
Samples were taken, total RNA was isolated and semi-quantitative RT-PCR was 
performed. RNA transcript levels were analyzed at 15 minutes and 30 minutes. 16S 
transcript levels were used as a control. Bands were visualized on a 1% agarose gel using 













Figure 17 – pgaB RT-PCR results for RprA RNA overexpression in A) 
Top10pRprA and B) MG1655pRprA. Top10 was transformed with pRprA (pBAD-
rprA) or a vector control (pBADHisA).  Cells were grown at 37oC in LB with 
ampicillin (50 µg/µL) when required. A control with no vector was also grown. At 
OD6000.3 cultures were induced with the indicated final arabinose concentrations. 
Samples were taken, total RNA was isolated and semi-quantitative RT-PCR was 
performed.  RNA transcript levels were analyzed at 15 minutes and 30 minutes. 16S 
transcript levels were used as a control. Bands were visualized on a 1% agarose gel using 








ycdT encodes a diguanylate cyclase that regulates motility in a cyclic-di-GMP 
(c-di-GMP) manner [149].  Overexpression of ycdT represses swimming behavior.  
In Figure 18A, ycdT, seemed to be upregulated in the Top10 cultures when plasmids 
are present, however, 0.2% and 2% cultures experience very minor decreases at 15 
minutes.  Top10 cultures at 30 minutes are pretty similar except for very modest 
increases in 0.02%, 0.2% and 2%.  In MG1655, the addition of inducer to the cultures 
results at minor increases in ycdT transcripts only in the pRprA systems especially at 
0.2% and 2% induction (Figure 18B).  This behavior is the same for 30 minutes.  
There is also a minor increase in the induced pBAD culture suggesting there may b  
an effect from plasmid induction with higher concentrations of arabinose.   It is 
important to note that total levels in both strains were not particularly high in general. 
 Finally, the lon gene, encodes for an ATP-dependent protease involved in the 
degradation of misfolded proteins.  In the MG1655, lon levels are similar for 15 
minutes but are appreciably lower by 30 minutes (Appendix).  Lon has been found to 
be negatively regulated by RpoS [150].  Other genes involved in biofilm actually 
decreased, like lldR and bssS [151, 152]. This highlights the complexity involved in 
biofilm formation and maturation and the cell signaling pathways involved.  It also 
supports why there are so many conflicting phenotypes observed. Other genes 
regulated were various inner and outer membrane proteins and nutrient transporters. 
Collectively, this data appears to suggest that the pRprA plays a part influencing the 
concerted regulation between motility, biofilm and stress response.  Other 
microarrays are in the works and we hope these will finalize the genetic profile





Figure 18 – ycdT RT-PCR results for RprA RNA overexpression in A) 
Top10pRprA and B) MG1655pRprA. Top10 was transformed with pRprA (pBAD-
rprA) or a vector control (pBADHisA).  Cells were grown at 37oC in LB with 
ampicillin (50 µg/µL) when required. A control with no vector was also grown. At 
OD6000.3 cultures were induced with the indicated final arabinose concentrations. 
Samples were taken, total RNA was isolated and semi-quantitative RT-PCR was 
performed.  RNA transcript levels were analyzed at 15 minutes and 30 minutes. 16S 
transcript levels were used as a control. Bands were visualized on a 1% agarose gel using 










pRprA system in other popular laboratory strains 
 We decided to transform the pRprA system into two other popular laboratory 
strains W3110 and MC4100.   The strains of W3110 in our laboratory stocks did not 
express any detectable levels of RpoS when processed by Western blots up to three 
hours post-induction.  This was not completely surprising considering the many 
studies revealing the numerous allelic versions of rp S across this strain, as well as 
other strains.  In original comparisons of the very similar genomes of MG1655 and 
W3110, rpoS was one of the genes with the greatest variation, even revealing 
nonfunctional alleles.  It was also not surprising considering the various source for 
attaining the strain and the polymorphic nature of rp S, especially with respect to 
storage conditions. 
 MC4100 contains a chromosomal deletion in the araD gene.  While this strain 
does not metabolize arabinose, the single deletion in the ara operon, without araA 
and araB, leaves this strain susceptible to arabinose toxicity [153].  We were 
intrigued by the idea of how this arabinose inducible pRprA overexpression system 
might perform in this strain.  Curiously, even in this strain, at one hour the cultures 
containing pRprA were higher, whether arabinose is present or not (Figure 19).  It is 
also interesting to note that the addition of arabinose to the pBAD culture does not 
result in the same kind of increase, indicating that the increase in RpoS levels the 
pRprA system is at least partially independent of any stress response inducd from 






















































































































Figure 19 – RpoS Western blot analysis of MC4100pRprA.  Cells were grown at 
37oC in LB.  At OD6000.3 cultures were induced with the indicated final arabinose 
concentrations. Whole cell protein samples were taken at the indicated time points. 
Samples were resuspended in protein loading buffer.  Ten microliter samples were 
used for SDS-PAGE and Western blotting.  Representative Western blots for the 
samples are shown (top).  Bands from the Western blots were quantified using Image 
J software and normalized against the Top10 control sample for each time point 
(bottom).  Error bars represent the standard of deviation for two replicates each for t 




pOxyS overexpression of oxyS transcript levels and corresponding RpoS protein 
levels 
   
 Overall the goal of the expression platform is that not only can various 
amounts of inducer be employed to express an sRNA, but that the small RNA, itself, 
can be easily substituted for a different effect on the RpoS genetic profile.  Since the 
first scenario used an activator, RprA, reasonably the system should be evaluated with 
a repressor, OxyS.  oxyS was cloned into the same site as rprA in the pBAD vector 
and tested under the same experimental conditions.  As in the previous case, 
overexpression of pOxyS resulted in detectable levels of OxyS RNA (Figure 20).  
Initially at 15 minutes, there is no detectable level in the uninduced plasmid, however, 
a low level of transcript is observed by one hour post-induction.   The level of 
transcript for all arabinose concentrations are similar except for the 0.002% culture 
which has moderately less.  Thirty minutes reveals equivalent amounts across all of 
the cultures expressing detectable levels of transcript.  Western blot analysis reveals 
that overexpression from pOxyS does reduce levels of RpoS protein levels especially 
in the 0.2% and 2% induced cultures by 30 minute post-induction (Figure 21).  This 
difference is abolished by one hour post-induction and RpoS levels return to control 
level.  This trend continues through three hour post-induction.   There is also a more 
modest decrease in the pBAD cultures, as well; however, the bands for these wer the 
same for the pRprA experiments.  This result reveals that the overexpression of OxyS 
RNA from the pOxyS system can effectively downregulate RpoS protein levels, 
though this knockdown by the repressor seemed to be more transient than the 





































Figure 20 – RT-PCR results for OxyS RNA overexpression in Top10pOxyS cells 
in response to arabinose. Top10 cultures were transformed with pOxyS (pBAD-
oxyS) or a vector control (pBADHisA).  Cells were grown at 37oC in LB with 
ampicillin (50 µg/µL) when required. A control with no vector was also grown. At 
OD6000.3 cultures were induced with the indicated final arabinose concentrations. 
Samples were taken, total RNA was isolated and semi-quantitative RT-PC was 
performed.  RNA levels were visualized at A) 15 minutes, B) 30 minutes and C) 1 
hour post-induction (HPI). 16S transcript levels were used as a control. Bands were 


















Figure 21 – RpoS Western blot analysis of Top10pOxyS.  Cells were grown at 
37oC in LB.  At OD6000.3 cultures were induced with the indicated final arabinose 
concentrations. Whole cell protein samples were taken at the indicated time points. 
Samples were resuspended in protein loading buffer.  Ten microliter samples were 
used for SDS-PAGE and Western blotting.  Representative Western blots for the 
samples are shown (top).  Bands from the Western blots were quantified using Image 
J software and normalized against the Top10 control sample for each time point 
(bottom).  Error bars represent the standard of deviation for two replicates each for t 















































































































 Given that the level of RpoS protein was decreased in the first 30 minutes of 
inducing the pOxyS system, we wanted to see if this would result in the opposite 
trend in the two RpoS-dependent genes tested previously in the pRprA system, bolA 
and flhD.   Based on semi-quantitative RT-PCR (Figure 22A), there were no 
appreciable differences in bolA transcription in any of the cultures containing a 
plasmid, though they all appear to be higher than Top10.  All bolA transcript levels 
are the same at 30 minutes.  For the fl D gene at 15 minutes, all induced cultures 
resulted in an obvious increase in flhD transcription levels indicating there may be an 
effect on flagellar synthesis just from the presence of a vector.  In any case, the 
cultures containing the pOxyS plasmid were still the highest. When comparing the 
Top10 control here with the one in the pRprA system it appears that the levels 
detected in this culture is low.  The difference seen here may just be an effect of 
experimental error and would most likely be rectified by repeating this experiment.  
What is most important here though is the fact that unlike the pRprA system, flhD 
does not decrease in the induced pOxyS cultures and is even markedly higher at 30 
minutes in pOxyS cultures induced with 0.02%-2% arabinose (Figure 22B).  This is 
the opposite trend experienced in the pRprA system.  This confirms the fact that not 
only is the platform effective for RpoS regulation by exchanging the sRNA, but this 










Figure 22 – bolA and flhD RT-PCR results for overexpression of Top10pOxyS. 
A) bolA and B) flhD. Top10 cultures were transformed with pOxyS (pBAD-oxyS) or 
a vector control (pBADHisA).  Cells were grown at 37oC in LB with ampicillin (50 
µg/µL) when required. A control with no vector was also grown. At OD600 0.3 
cultures were induced with the indicated final arabinose concentrations. RNA 
transcript levels were visualized at 15 minutes and 30 minutes. 16S transcript levels 
were used as a control. Overexpression of OxyS RNA had no effect on bolA 
transcript levels but effectively decreased flhD transcript levels in induced pRprA 
cultures at 30 minutes. Bands were visualized on a 1% agarose gel using ethidium bromide 












We have shown that the small RNA platform can effectively regulate RpoS 
protein levels both positively and negatively by the overexpression of both RprA and 
OxyS RNA from an arabinose inducible promoter and that this regulation can be 
further tuned by varying the concentration of the inducer.  Moreover, the system also 
modulates the expression of both previously shown RpoS-dependent and independent 
genes.  A comparison of the overexpression of RprA to the overexpression of RpoS 
also shows variations in gene and level of regulation.  This is probably partially due 
to the fact that both systems will recruit different groups of genes for cellular 
interactions though they both increase RpoS levels.  The extent of RpoS protein levels 
produced in the pRpoS plasmids no doubt elicits many stress response genes to 
address aggregation and inclusion bodies.  RprA does not seem to increase the levels 
of traditionally identified heat shock proteins upon overproduction.  RprA is a native 
RNA and the short transcripts may not be as taxing on overall cellular functions.  
Furthermore, RprA is induced upon sensing osmotic shock, meaning while the 
complete mechanism for how this signal transduction functions is unknown, it would 
be reasonable to assume that other genes are sequestered to address the particular 
stress as well.  There may be a more specific assembly of genes that RprA enlists.   
This is another major goal of using such a platform because small RNAs may address 
stress from a more holistic perspective than trying to affect change at a single point.  
Assuming the small RNAs controlling RpoS regulation are not redundant than there 
may be a specific subset of different genes utilized by each sRNA to address its 




platform.  RpoS has so many influences in the cell regulatory network, simply 
overexpressing RpoS would not necessarily be indicative of the stress that needs to b  
addressed.  The pRpoS system alone may not upregulate the necessary genes to 
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Chapter 3: Downstream Phenotypic Effects Conferred by the 




Escherichia coli have been used as a model organism for many years now and 
have garnered a great deal of both fundamental and specific information about 
cellular function.  As more details are elucidated, however, the puzzle seemsto grow 
more complex.  Understanding of some of the elementary inner workings has led to 
the question of how such closely related strains have attained so much diversity, now 
referred to in some areas as genomic plasticity [154] .   While there exist many 
universal concepts to bacterial regulation there are clearly just as many that have 
seemed to divergently evolve.  This is very prominent when working with K-12 
strains as the genomes for wild-type strains, where MG1655, W3110 and MC4100 
have all been varied significantly in the laboratory setting even under the same 
conditions.  This diversity has resulted in the realization that though similar, these 
strains may have differences in their regulatory networks, even within the same strain.  
Closer examination has revealed that in many cases, differential gene expression was 
at least partly due to RpoS and its dependent regulon.  What has become even more 
fascinating is the extent to which this gene can influence these disparities in both gene 
expression and utility. 
 The evolution of the RpoS regulon has revealed that though its function is 
highly conserved across species it  may be compiled of different genes depending on 
environmental conditions [155].  RpoS, as a global stress response, has the main goal 




surroundings as such, to the point that it even allows for its own mutation, or loss.  
Many of the genes in the RpoS regulon are considered nonessential in absence of 
stress which is why it is so amenable to selective pressure [156].   The ability to sense 
environmental stimuli and alter gene expression to adapt to dynamic surroundings 
rationally means RpoS, is dynamic itself, and as such it is difficult, if not impossible, 
to predict exactly how it will influence the cell to behave in any situation.  Despite 
this many efforts have be launched to discern the expression profile of RpoS in a 
variety of scenarios under various growth phases (exponential, stationary and in 
biofilm), stress conditions, in different strains (e.g. MG1655 and MC4100) and media 
(e.g. LB and M9 minimal) and via different methods (e.g. DNA microarray and lacZ-
fusions) [7, 50, 52, 55, 111].  While many conserved genes and cellular function have 
been elucidated, the fact remains that RpoS gene regulation is highly dependent on 
the given conditions.   However, even in stating this fact, it is undeniable that RpoS 
regulation, and stress response obviously plays an immense role in the genotypic and 
phenotypic diversity witnessed today.   
 The duality of the RpoS stress regulation role, which is comprised of 
both preventive and acute strategies, is implicated in the variety witnessed in 
traditional, and engineered, cellular functions and behaviors.  RpoS alternates these 
roles and works in concert with other global networks, such as quorum sensing, to 
affect cross-protection, pathogenicity, motility, biofilm and even in recombinant 
protein production.  As RpoS plays a role in each of these conditions, modulation of 






A major function of the general stress response is preventative. This fact 
becomes increasingly evident in incidences where microorganisms are exposed to 
short, sub-lethal doses of one particular stress.  These same organisms then develop 
high resistance to subsequent sources of the same or different stress chall nges [157].  
Cross- protection is the term ascribed to this phenomenon and is at least partially 
mediated by σS, which renders cells broadly stress resistant [158, 159].  Several prior 
research efforts have shown that exposure to small amounts of one stress (e.g. carbon 
starvation, heat shock, metal toxicity, etc.) resulted in reduced hypersensitivity to a 
secondary stressor due to an amplification of rp S mRNA translation [160]. 
 
Biofilm formation and antibiotic resistance 
 While bacteria grown in the lab is usually studied as planktonic cultures, 
bacteria by and large naturally exist as sessile, surface-adherent communities called 
biofilms [161].  Biofilm tolerance is of major importance because it directly relates to 
the decrease in antibiotic efficacy against acute infections and bacterial pathogenicity 
[162, 163].  This is of major concern because diverse kinds of polymicrobial 
infections are biofilm based including implant related infections, dental caries, nd 
respiratory infections [162, 164]. The survival strategy of bacterial biofilms is similar 
to the stress tolerance experienced by planktonic cultures during stationary phase, 
including nutrient starvation and cessation of growth [53].     Current work indicates 
that refractory resistance to antibiotic killing is contributed to by induction of an 




diversity that leads to antibiotic-tolerant variants or persistors.  RpoS is an attr ctive 
target for new antimicrobial strategies because this regulator controls many of the 
genes important for bacterial adaptation to the host environment.  It has been shown 
that RpoS has both direct and indirect roles in pathogenicity and virulence [167, 168].  
This is true also because many stress-associated genes are expressed during biofilm 
development.  In fact stress responses can increase biofilm formation.  Rp S mutant 
E. coli have been shown to dramatically impaired in biofilm growth [53, 145, 151, 
152].   On the other hand, the engineering of biofilms and their robustness has made 
them ideal candidates for biotechnology applications such as bioremediation, 
biofuels, the treatment of diseases and BioMEMS devices [169]. 
Recombinant DNA technology and recombinant protein-induced stress 
Recombinant DNA technology has allowed the modification of 
microorganisms, such as E. coli, for the purpose of producing many therapeutic 
proteins, become the accepted mode of bioprocessing.  The host organism then uses 
its own cellular machinery to manufacture the desired protein usually placed under 
the control of an inducible promoter system.  The expression of this foreign protein 
however elicits a rapid stress response due to the metabolic burden incurred by th  
host to perform this additional task [170]. This stress response is partially mediated 
by σS, accompanying the heat shock sigma factor, σ32, which is transiently induced 
and stabilized during recombinant protein production [171, 172].  A multitude of 
chaperone proteins and proteases respond to attempt to refold or degrade misfolded 
foreign proteins.  The protein that remains often exists in an aggregated state 




efforts at optimizing foreign protein production tend to focus on the exponential 
growth phase of the cells attempting to improve the growth conditions and 
maximizing protein yield before the stress response transpires (e.g. boosting aeration 
or nutrient supply).  Other efforts focus on combating the stress response itself by 
transiently downregulating proteases, upregulating the production of chaperone 
proteins, or both [123].  At the same time, the resistance given to the cell through 
RpoS regulation creates a very robust organism that is capable of taking over younger 
cultures.  Many successful approaches that help to negate this burden have been to 
use the intracellular molecules in quorum sensing communication [174].  It has also 
been shown there are situations when losing RpoS function becomes a selective 
advantage, or the growth advantage in stationary phase (GASP) phenotype [175].     
This is due to the trade-off between growth and proliferation nurtured by σ70 and the 
survival promoted by σS.    Additionally, other studies reveal that in early stationary 
phase E. coli cells are still fit for recombinant protein production probably due to 
RpoS mutations  [176]. 
As RpoS plays a role in each of these conditions, modulation of RpoS could, 
in turn, potentially modulate the given associated phenotypes.  It is becoming 
increasingly evident that impactful solutions to these types of issues must account for 
not only the cell itself but the cell in context of the entire surrounding area, because 
many cellular systems are working complementarily. The revelation that both the 
pRprA and pOxyS overexpression platforms can effectually modulate RpoS protein 
levels and downstream RpoS-dependent and independent genes inspired a study to 




modified by either system.   For this purpose, we evaluated both platforms in tests of 
glycogen synthesis, aggregation, motility, biofilm formation and recombinant protein 
production. 
 
Materials and Methods 
Bacterial strains and growth conditions 
Bacterial strains used are included in Table 2.  Overnight cell cultures wer 
inoculated in 5 mL of Luria-Bertani broth (LB) to an OD600 0.01 in a 15 mL culture 
tube.  Cultures were grown at 37oC with 250 rpm shaking to an OD600 0.3 at which 
point.  Cultures were then induced for RprA or OxyS sRNA transcription with the 
appropriate concentration of 0.2% L-arabinose. 
GFPuv plasmid construction 
GFPuv was cloned from pTrcHisGFP [177] with new restriction sites KpnI 
and EcoRI  to be reinserted into the pTrcHisB vector (Invitrogen) with the following 
primers: sRNAGFP_For (5’- TCG CCC ATG GAC GGT TAT AAA TCA AC- 3’) 
and sRNAGFP_Rev (5’- ACT TAA GCT TAA AAA AAG CCC ATC GT- 3’).  The 
entire segment from the araC gene until the transcription terminator site was cloned 
from both pRprA and pOxyS and inserted into sites of the pTrcHisB vector to give 
pTrcGFP_pRprA and pTrcGFP_pOxyS respectively with the following primer set: 
both used forward primer smallRNAKpnI_For (5’- CGT CGG TAC CTT ATG ACA 
ACT TGA- 3’) and reverse primers RprAEcoRI_Rev (5’- CCG GAA TTC AAA 
AAA AGC CCA TCG’) and OxySEcoRI_Rev (5’- CTT GAA TTC AGC GGA TCC 





Five milliliter cultures were inoculated to an OD600 0.01 from overnight 
cultures at 37oC and 250 rpm shaking.  Cultures were grown to an OD600 0.3 and a 10 
µL drop of each culture was inoculated in the middle of individual motility plates 
(0.5% Bacto-tryptone, 0.5% NaCl, and 0.3% agar).  An arabinose concentration of 
0.2% was added to induce cultures and cultures were allowed to grow for one hour.  
10 µL drops were inoculated on new motility plates.  The process was repeated at two 
hours post-induction.  All plates were place in the incubator after inoculation and 
allowed to grow for 48 hours at 37oC.  MG1655 experiments were the same except 
the induced culture was only allowed to grow for a half an hour because of the 
arabinose metabolism capability of the strain.  These plates were also only incubated 
for 12 hours due to faster growth. 
 
Biofilm Assay 
Five milliliter cultures were inoculated to an OD600 0.01 from overnight 
cultures at 30oC and 250 rpm shaking.  Cultures were grown to an OD600 0.3 at which 
time 0.2% arabinose was added to induce cultures and all cultures were allowed to 
grow for one hour.  Cultures were diluted to an OD600 0.05 and 200 µL was added to 
a 96-well microtiter plate with five replicates each.  Duplicate plates were made for 
each point of analysis, 24 hours and 48 hours.  Plates were grown at 30oC without 
shaking for 24 and 48 hours.  After taking an OD600 reading, plates were washed with 
distilled water and 0.1% crystal violet was added to each well.  After 20 minutes, the 




crystal violet stain was solubilized by 200 µL 95% ethanol and the OD540 of the 
suspension was measured. 
 
Aggregation Assay 
 Overnight cultures of the strains were adjusted to approximately the same 
optical density at OD600 1, and 10 ml of each culture was placed in a sterile 15-ml 
Falcon tube. At the beginning of each experiment, all cultures were vigorously shaken 
for 10 seconds. Two 100-µl samples were taken from each tube, approximately 1 cm 
from the top, and transferred to two new tubes, each containing 1 ml of 0.9% NaCl. 
The OD600 was then measured for both samples at the indicted time points. 
 
Glycogen synthesis and iodine vapor staining 
Five milliliter cultures were inoculated to an OD600 0.01 from overnight 
cultures at 37oC and 250 rpm shaking.  Cultures were grown to an OD600 0.3 at which 
time 0.2% arabinose was added to induce cultures and all cultures were allowed to 
grow for one hour.  Each experimental culture was streaked on a Kornberg medium 
(0.85% KH2PO4, 1.1% K2HPO4, 0.6% yeast extract, and 1.5% agar) plate in parallel 
with control cultures.  Plates were grown overnight at 37oC and then stored at 4oC for 







Results and Discussion 
Glycogen accumulation 
 glgS is an RpoS-dependent  gene responsible for glycogen synthesis in E. coli.  
There is still some speculation of the reason for glycogen accumulation in bacteria 
but it is thought to provide energy for organisms in unfavorable environments, 
especially if it can be accumulated.  Overexpression of RpoS and consequently glgS 
results in higher glycogen biosynthesis levels that can be visualized by dark brown 
staining with iodine on glucose-rich Kornberg medium plates.  In looking to attain n 
RpoS-dependent gene phenotype we tested for glycogen levels expressed in pRprA 
and pOxyS induced cultures in both Top10 and MG1655.  Figure 23 reveals the 
darkest brown for Top10 and both pBAD cultures.  The pRprA containing cultures 
exhibit slightly less glycogen accumulation, indicating a lower level of Rp S or an 
indirect effect on or production.  On the other hand, Top10_pOxyS cultures, whether 
induced or not, contain much lower glycogen levels than any other producing 
cultures.  This result suggests that RpoS may really be repressed upon expression of 
OxyS.  There is also a level of leaky expression from the vectors without the addition 
of arabinose.  This constitutive expression seems to be enough to repress glycogen 
synthesis.   The same process was repeated with the MG1655 and in this case while 
there was no difference between induced and uninduced cultures the pRprA cultures 
were the same as the controls (Figure 24A).   Interestingly, in MG1655 the pOxyS 
cultures have the opposite effect and actually stain darker indicating the activation, 







Figure 23 – Glycogen synthesis in Top10pRprA and Top10pOxyS.  Top10 was 
transformed with pRprA (pBAD-rprA),  pOxyS (pBAD-oxyS) or a vector control 
(pBADHisA).  Cells were grown at 37oC in LB with ampicillin broth. A control with 
no vector was also grown. At OD6000.3 cultures the indicated cultures were induced 
with a 0.2% final concentration of arabinose. At 1 HPI cultures were plated on 
Kornberg medium plates.  Plates were grown at 37oC overnight, stored at 4oC for 24 
hours and vapor stained with iodine.   The intensity of the brown stain reveals the 
extent of glycogen accumulation. There was no obvious difference between cultures 






















Figure 24 – Glycogen synthesis in MG1655pRprA and MG1655pOxyS.  MG1655 
was transformed with pRprA (pBAD-rprA), pOxyS (pBAD-oxyS) or a vector control 
(pBADHisA).  Cells were grown at 37oC in LB with ampicillin broth. A control with 
no vector was also grown. At OD6000.3 cultures the indicated cultures were induced 
with a 0.2% final concentration of arabinose. At 0.5 HPI cultures were plated on 
Kornberg medium plates.  Plates were grown at 37oC overnight, stored at 4oC for 24 
hours and vapor stained with iodine.   The intensity of the brown stain reveals the 
extent of glycogen accumulation in A) pRprA and B) pOxyS in MG1655. There was 




accumulation.   This indicates again that the same expression system has the 
capabilities of altering strains differently. 
 
The small RNA overexpression system effects motility  
 Bacteria that move seem to try to in a purposeful way, especially in respons 
to their surroundings.  They are capable of moving away from toxins or towards 
nutrients in order to survive their ever changing settings.  In the evaluation of the 
gene expression profiles in the sRNA platforms, flhD, was regulated in both strains 
and in opposite directions, a decrease for the activator and an increase for the 
repressor.  flhD is part of the Class I master transcriptional regulator operon flhDCfor 
flagellar synthesis.  The Class I genes activate the Class II  genes that encode the 
structural genes , which then activate the Class III genes that are responsible for 
chemotaxis and flagellar filament [142].  In light of these findings we chose to do 
motility tests to see is this translated into a logical motility phenotype.  Each of the 
expression systems, pRprA and pOxyS were compared to control strains, Top10, 
Top10pBAD and a 0.2% induced Top10pBAD culture.  The expression systems both 
had an induced and uninduced culture.  Prior to, as well as, 1 and 2 hours after 
arabinose induction, a small drop was placed on motility plates and allowed to grow 
for 48 hours.  There was no detectable difference in growth at 24 hours.  Figure 25A 
displays the qualitative differences in the motility halos of each test culture at 48 
hours post-induction.  While initially all the cultures displayed large colony sizes, 
after induction, the cultures induced to overexpress RprA, had very small colonies.  





Figure 25 – Motility assay for Top10pRprA.  A)  Qualitative differences in 
motility halos grown at 30oC for 48 HPI on motility agar. B) Average diameters of 
motility halos prepared at each time post-induction. Values are the average of 2 to 4 








cultures are three fold lower than all the other cultures tested (Figure 25B). The same 
experiment with pOxyS showed no discernable differences in halo size. 
The same experiment was repeated for MG1655 except plates were only 
prepared for one hour post-induction and the plates were grown for only 12 hours.  
Growth in MG1655 can be almost twice as fast as Top10.  This is also reflected in the 
generally larger size of the halos.   In Figure 26A, a quantitative representation of the 
differences in motility halos is shown.  A very modest decrease may be detecte  in 
the induced pRprA culture.  The same is true for both of the pOxyS cultures Figure 
26B.  The results from either expression system in MG1655 were not as dramatic s 
Top10pRprA. This strain also seemed to have greater instances of fluctuation that 
masked the actual behavioral differences (i.e. large error bars).  The addition of either 
of the small RNA expression systems had no effect when induced in W3110, this too 





























































Figure 26 – Motility assay for MG1655 with A)  pRprA and B) pOxyS.  Average 
diameter measurements of motility halos of cultures inoculated on motility agar 
grown for 12 hours post-induction. Values are the average of 2 to 4 plates from three 











Figure 27 – Biofilm formation assay for Top10.  A)  pRprA and B) pOxyS. 
Biofilm was grown in LB in 96-well plates at 30oC with no shaking for the 
indicated time points. The biofilm was stained with 0.1% crystal violet and 
solubilized with 95% EtoH. The solubilized biomass was measured at OD540. 
Reported biofilm is biomass measured at OD540 normalized to the OD600 value 
for that well at 24 or 48 hours. Values are the average of two plates with five 
replicates from at least two independent experiments.  Error bars represent th  






 The pRprA expression system also has an effect on biofilm formation 
If the pRprA had an effect on motility it would be reasonable to suspect a 
difference in biofilm formation, considering flagellar genes are required for biofilm 
formation.   For the biofilm assay cultures were set up as described in the Materials 
and Methods section.  The results are presented in Figure 28A and B, for pRprA and 
pOxyS respectively.  While there is no difference in biofilm formation at all in the 
pOxyS cultures in Top10.  An induced pRprA culture is almost 12-fold higher than 
the control cultures at 24 hours and almost 6-fold higher at 48 hours.  This 
corresponds to what would be expected in cultures that both showed a decrease in 
flhD and motility. 
As with the RT-PCR and Western blot data, we wanted to see if this huge 
increase in biofilm formation was solely due to an overexpression of RpoS protein 
levels.  The biofilm assay was repeated comparing pRprA and pRpoS and the results 
are displayed in Figure 28.  While the increase in biofilm formation previously 
observed in Top10pRprA cultures is present, a direct induction of RpoS alone does 
not increase biofilm formation.  This also suggests what may be another advantage to 
increasing RpoS protein levels via sRNA overexpression systems is the potential  to 
more effectively recruit other genes to facilitate the control.  Overexpressing small 









Figure 28 – Biofilm formation assay for Top10pRprA and Top10pRpoS.  
Biofilm was grown in LB in 96-well plates at 30oC with no shaking for the 
indicated time points. The biofilm was stained with 0.1% crystal violet and 
solubilized with 95% EtoH. The solubilized biomass was measured at OD540. 
Reported biofilm is biomass measured at OD540 normalized to the OD600 value 
for that well at 24 or 48 hours. Values are the average of two plates with five 
replicates from at least two independent experiments.  Error bars represent the 












The experiment was repeated with each system in the MG1655 strain.  Figure 
29A shows that the presence of any vector in this strain decreases biofilm formation 
regardless of induction, pBAD or pRprA.  MG1655 is almost six times higher than all 
of the other cultures.  MG1655, as the wild type, does produce good biofilm so it’s 
interesting that a plasmid reduces it to barely detectable.  Perhaps just the presence of 
the vector in this strain at 30oC results in another stress and stress factor being 
recruited, confirming that several coordinated factors go into the formation of biofilm 
other than just the presence of RpoS.  The biofilm formation is however recovered 
with the pOxyS expression system (Figure 29B).  This is in contrast with what is 
expected from the repressor system but in line with the other phenotypes witnessed in 
this strain.  It has also been shown recently that the regulation of motility is actually 
dependent on antagonistic control between RpoS and σ54, RpoN which also controls 
flagellar genes.   While a mutant of rpoS or rpoN, results in decreased and increased 
motility respectively, a double mutant abolishes motility [178].  Biofilm formation in 
W3110 remained unchanged from the wild type and in MC4100 biofilm formation 


















Figure 29 – Biofilm formation assay for MG1655.  A)  pRprA and B) 
pOxyS Biofilm was grown in LB in 96-well plates at 30oC with no shaking for 
the indicated time points. The biofilm was stained with 0.1% crystal violet and 
solubilized with 95% EtoH. The solubilized biomass was measured at OD540. 
Reported biofilm is biomass measured at OD540 normalized to the OD600 value 
for that well at 24 or 48 hours. Values are the average of two plates with five 
replicates from at least two independent experiments.  Error bars represent th  








Autoaggregation and pRprA and pOxyS systems 
 Unexpectedly while performing other experiments, we noticed that there 
seemed to be a difference in settling from overnight culture in strain MC4100 with 
cultures containing pRprA remaining suspended long after the other cultures had 
settled.  A study on biofilm and quorum sensing by our lab had revealed a role for the 
flu encoded, antigen 43 (Ag43) [179].  We decide we would perform an aggregation 
assay on this system.  Experiments were conducted as described in the Materials and 
Methods but briefly overnight cultures were resuspended to OD600 1.  100 µl samples 
were taken at the indicated time points and added to 1ml of 0.95 NaCl and the OD600 
was read.   As we suspected cultures containing the pRprA vector experienced a 
slower aggregation rate than the other cultures with the induced culture being almost 
4 times slower than controls at its highest point (Figure 30A).  The uninduced culture 
aggregated slightly faster.  While the aggregation of the control cultures was resolved 
in about 24 hours, it took 2 days for the induced pRprA culture.  The uninduced 
culture initially started off as high as the induced but by 36 hours it had settled as 
well, appearing to have a much steeper slope.  Induced pOxyS culture experience 
about a 2-fold slower difference in aggregation rate as compared to the other controls 
but was also resolved by 24 hours (Figure 30B).  If Ag43 positively mediates cell-cell 
aggregation and biofilm [180], this shows how RpoS is working in concert with many 
other genes to affect protective habits and survive.  This gene could also have a part 
in the biofilm effect witnessed earlier with pRprA but also proves how much strains 









Figure 30 –Aggregation assay for MC4100.  A)  pRprA and B) OxyS. 
Time-resolved differences in rates of cell sedimation (see Materials and 
Methods). Values are the average of triplicate readings.  Error bars represent 






pRprA may attenuate GFPuv recombinant protein production 
 
 Finally, we wanted to test if maybe the overexpression of either expression 
platform could increase recombinant protein production, either by cross-protection or 
by repressing RpoS so that σ70 could continue to grow and proliferate.  Figures 31A 
and B show that induction of either pRprA or pOxyS did not significantly increase 
protein production.  In the pOxyS 0.2% culture, only 10HPI shows a modest increase 
in GFP production (Figure 31B).  The lack of significant enhancement could signify 
that the pRprA and pOxyS systems are not useful for increasing recombinant protein
production, even if the system may be increasing stress protective genes.  However, it 
does seem that GFP production seems to be attenuated with increase of expression.  
By 10 hours all of the cultures share similar OD600 readings except for 2%.  Perhaps 
the system can be considered a negative switch.  Furthermore, GFPuv heterologous 
protein production has been shown to be very high and fairly soluble naturally.  It 
could be that there was not much room left for optimization using the sRNA platform 
























Figure 30 – Fluorescence for GFPuv recombinant protein production in 
MG1655 for A) pRprA and B) OxyS.  Values represent experimental fluorescence 
value minus the background fluorescence of LB and are the average of triplicate 








 In addition to controlling the genetic expression profile for RpoS, the pRprA 
and pOxyS riboregulatory platforms can effectively increase and decreas  RpoS 
levels and effect downstream genes, even some which have not been identified as 
RpoS-dependent.  This is due to both the polymorphic nature of RpoS and how it will 
adapt to its surroundings.  Even with the same level of RpoS by different stresses, 
regulatory mechanisms will be different depending on the state of the environment.  
Depending on the sRNA used in the system, RprA or OxyS, the concentration of 
inducer and the strain we saw altered regulation of glycogen accumulation, motility, 









Chapter 4: Conclusions and Future Work 
 
General Conclusions 
 We have successfully engineered an inducible sRNA riboregulatory platform 
that can be changed to direct desired phenotypic events.  Explicit overexpression of 
different sRNAs allowed for the transient increase/attenuation of RpoS protein lev ls 
that altered the gene expression profile of the cell.  We were able to show that in this 
time we could also upregulate a protective RpoS-dependent, glgS, which provides 
some evidence that conceivably we can purposefully upregulate other protective 
genes and enhance bacterial cell fitness.  Concomitantly, this regulation was extended 
to specifically affect cell motility and aggregation, showing the capacity to direct the 
regulation of the cell’s most fundamental behaviors for survival.  From this study, one 
of the most exciting modes of modulation was in control of biofilm formation, which 
has also been shown to influence biofilm formation and architecture.  If biofilms 
could be controlled by genetic manipulation then they could be formed at specific 
locations and engineered to treat disease or produce certain chemicals.  Due to the 
protective state of biofilms and their robustness, they facilitate enhanced gen  transfer 
and communication signaling.  This has been successfully used to create biofilm
reactors used for bioremediation of waste water and industrial streams using bacterial 
degradation of pollutants.  Engineered biofilms have been used for delivery of drugs 
and nutrients.  These biofilm have also been used for treatment of bacterial biofilm




in patients suffering from the disease.  Biofilm reactors have also been used for 
biofuel production.   
 The biggest limitation of the sRNA regulatory expression platform is that 
there will likely be altered expression of genes that result in unintended effects, 
especially considering the mechanisms of these small RNAs are still being 
investigated.  Nonetheless, while the complete mechanism for how this signal 
transduction functions is unknown, it would be logical to assume that other genes are 
sequestered to address the particular stress as well.  There may be a more specific 
assembly of genes that small RNAs enlist that are not solicited by overexpr ssing a 
single gene.   Additionally, this gene set can potentially be changed to suita desired 
application by changing the sRNA employed and changing inducer concentration.  
This is the major goal of using such a platform because small RNAs may address 
stress from a more holistic perspective than trying to affect change at a single point 
effecting global regulation.  The inducible sRNA regulatory platform has shown that 
gene regulation can be globally tuned to have a range of physiological effects using 
variable amounts of inducer and diverse sRNA overexpression systems, providing 




 Though this system needs more characterization it has shown promise in 
influencing RpoS regulation.  It would be ideal to see a microarray done for the 




the promise in using microarrays for determining targets of small RNAs.  
Traditionally, gene regulatory functions are assessed by comparing the wild type  
expression to a mutant of that gene.  This is not practical for small RNAs because 
they are not active unless a stress is encountered, so any changes in genetic profil  
would hardly be discernable.  The small RNA overexpression system shows the 
promise in using microarray to collect a gene profile of a least potential targets for 
small RNAs provided proper controls are used.  This was just employed by Susan 
Gottesman in the identification of a small RNA involved in luxS and quorum sensing 
regulation [181].  In addition, investigating the use of other inducers both chemical 
and natural would be desirable.  This would allow even more fine tuning for 
particular systems.  The idea that strain differences can be so dramatically lter gene 
expression profiles makes it interesting to evaluate the rpoS gene from one strain in 
another strain. One can then compare the potential differences of the same rpoS allele 
in different strains.  This will be telling to see how many other systems are involved 
in many RpoS related behaviors.  Finally, to create an optimized system by having 
different activator/repressor combinations would find many biotechnology 
applications. 
Prospects for the future 
 The fact that RpoS has four sRNAs regulating its translation, under different 
conditions, raises the question of whether this phenomenon is distinctive, or 
indicative of a much greater potential for sRNA regulation.  Knowledge garnered 




identified with no known function, revealing higher levels of mechanistic regulation 
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